{"gene":"PAK1","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1999,"finding":"PAK1 directly phosphorylates LIM-kinase at threonine 508 within its activation loop, increasing LIM-kinase-mediated phosphorylation of cofilin tenfold in vitro; activated Rac/Cdc42 increases PAK1-LIMK association requiring both N-terminal regulatory and C-terminal catalytic domains of PAK1, thereby coupling Rac/Cdc42 signaling to actin depolymerization","method":"In vitro kinase assay, co-immunoprecipitation, dominant-negative interference, PAK1 autoinhibitory domain peptide inhibitor","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis, replicated across multiple orthogonal methods in a highly-cited foundational paper","pmids":["10559936"],"is_preprint":false},{"year":1995,"finding":"PAK1 acts as a downstream mediator of Rac/Cdc42 GTPases to activate the p38 MAP kinase; dominant-negative PAK1 suppresses both IL-1- and Rac/Cdc42-induced p38 activity, placing PAK1 in a kinase cascade leading to p38 and JNK activation","method":"Co-expression of constitutively active/dominant-negative GTPases and PAK1, p38 kinase activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — epistasis with dominant-negative constructs, highly cited, replicated","pmids":["7592586"],"is_preprint":false},{"year":1997,"finding":"PAK1 regulates actin cytoskeletal organization in mammalian cells; microinjection of activated PAK1 induces filopodia and membrane ruffles; PAK1 N-terminal mutants that cannot bind Cdc42/Rac1 show enhanced binding to the adapter protein Nck via a proline-rich SH3-binding region, and mutation of this proline residue alters cytoskeletal effects","method":"Microinjection, overexpression of mutants, co-immunoprecipitation, fluorescence microscopy","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, highly cited foundational paper","pmids":["9395435"],"is_preprint":false},{"year":1996,"finding":"PAK1 specifically interacts with the Nck adapter protein both in vitro and in vivo; Nck binds PAK1 through its second SH3 domain while PAK1 interacts with Nck via its first proline-rich SH3-binding motif; active PAK1 phosphorylates Nck at multiple sites; this interaction is strengthened upon PDGF receptor stimulation","method":"Co-immunoprecipitation, in vitro binding assay, in vivo phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus in vitro binding with domain mapping","pmids":["8824201"],"is_preprint":false},{"year":1997,"finding":"Endogenous PAK1 localizes to pinocytic vesicles and co-localizes with F-actin in membrane ruffles and lamellipodia upon PDGF stimulation or Rac1 activation; PAK1 precedes F-actin in translocating to peripheral cytoskeletal structures; co-immunoprecipitation demonstrates in vivo interaction of PAK1 with filamentous actin; localization to actin structures is blocked by cytochalasin D and wortmannin","method":"Immunofluorescence microscopy, subcellular fractionation, co-immunoprecipitation, microinjection, pharmacological inhibition","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — direct localization with functional consequence, multiple orthogonal methods","pmids":["9298982"],"is_preprint":false},{"year":1999,"finding":"Constitutively active PAK1 increases myosin light chain (MLC) phosphorylation and promotes directional cell motility; kinase-dead PAK1 has no effect on MLC phosphorylation and causes defects in directed motility; PAK1 kinase activity is required for polarized lamellipodia formation and persistent directional movement on fibronectin","method":"Tetracycline-inducible expression of wild-type, kinase-dead, and constitutively active PAK1; F-actin staining; MLC phosphorylation western blot; motility and chemotaxis assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — clean inducible KO/OE with defined molecular readouts and functional phenotypes","pmids":["10330410"],"is_preprint":false},{"year":2000,"finding":"Activated (phosphorylated) PAK1 localizes to focal adhesions, filopodia, and lamellipodia edges in response to Cdc42/Rac1 or PDGF stimulation; PAK1 activation during wound closure is rapid, localizes to the leading edge, and is blocked by PI3-kinase and Src family kinase inhibitors but not EGFR inhibitor","method":"Phospho-specific antibody immunofluorescence, pharmacological inhibition, wound-healing assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — activation-state-specific antibody with direct spatial and temporal mapping, functional pharmacological dissection","pmids":["11134074"],"is_preprint":false},{"year":2001,"finding":"PAK1 directly associates with Raf-1 in a manner dependent on PAK1's active conformation; active PAK1 phosphorylates Raf-1 at Ser338, a critical step for Raf-1 activation; the Raf-1 binding site maps to the C-terminus of the PAK1 catalytic domain; kinase-dead PAK1 barely binds Raf-1","method":"Co-immunoprecipitation under physiological and overexpressed conditions, in vitro kinase assay, domain mapping with deletion mutants, active-site mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with mutagenesis plus co-IP domain mapping","pmids":["11733498"],"is_preprint":false},{"year":2002,"finding":"PI-3 kinase associates with the N-terminal regulatory domain (amino acids 67-150) of PAK1 in a Cdc42/Rac1-independent manner, leading to PAK1 activation; activated PAK1 directly phosphorylates actin, resulting in stress fiber dissolution and microfilament redistribution; kinase-dead PAK1 (K299R) and autoinhibitory domain peptide block actin phosphorylation","method":"Co-immunoprecipitation, in vitro kinase assay, domain mapping with deletion/point mutants, cytoskeletal imaging","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with active-site mutagenesis and domain mapping","pmids":["12181358"],"is_preprint":false},{"year":2003,"finding":"PAK1 physically interacts with protein phosphatase 2A (PP2A) and localizes to Z-disk, cell membrane, intercalated disc, and nuclear membrane in rat cardiac myocytes; constitutively active PAK1 reduces phosphorylation of cardiac troponin I (cTnI) and myosin binding protein C, associated with increased Ca2+ sensitivity","method":"Co-immunoprecipitation, adenoviral overexpression, immunofluorescence, Ca2+-tension measurements","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — direct localization with functional consequence, reciprocal Co-IP","pmids":["14670848"],"is_preprint":false},{"year":2003,"finding":"PAK1 interacts with the Grb2 adapter protein via its second proline-rich SH3-binding domain; Grb2 mediates PAK1 association with the activated EGFR; blockade of this interaction by a cell-permeant TAT-tagged peptide decreased EGF-induced membrane lamellar extension","method":"Co-immunoprecipitation, in vitro binding, TAT-peptide competition assay, cell morphology analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vitro and in vivo Co-IP with domain mapping and functional consequence","pmids":["12522133"],"is_preprint":false},{"year":2003,"finding":"PAK1 Thr212 is phosphorylated by Cdk5 (p35/Cdk5) or cyclin B1/Cdc2 in postmitotic neurons and mitotic cells respectively; developmental analysis shows Pak1T212(PO4) accumulates in corpus callosum, intermediate zone, and olfactory/commissural tracts in embryonic forebrain, and is absent in adult tissues","method":"Phospho-specific antibody immunofluorescence, developmental expression analysis, site-specific biochemical characterization","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 3 — phospho-specific antibody localization, no direct functional rescue in this paper","pmids":["12950086"],"is_preprint":false},{"year":2005,"finding":"Crystal structures of the free PAK1 kinase domain at 1.8 Å resolution reveal an essentially active conformation even without phosphorylation of Thr423; a phosphomimetic activation-loop mutation yields a very similar active conformation; the unphosphorylated kinase domain adopts an 'intermediate-active' state upon release from autoinhibitory dimerization","method":"X-ray crystallography at 1.8 Å, active-site and activation-loop mutagenesis","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with mutagenesis validation","pmids":["15893667"],"is_preprint":false},{"year":2005,"finding":"CIB1, a 22-kDa Ca2+-binding protein, directly and specifically interacts with PAK1 within discrete regions surrounding the inhibitory switch domain in a calcium-dependent manner, activating PAK1 both in vitro and in vivo; CIB1 overexpression decreases cell migration through a PAK1/LIM kinase-dependent increase in cofilin phosphorylation; siRNA depletion of CIB1 reduces adhesion-induced PAK1 activation","method":"Pulldown, co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, cell migration assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus in vitro kinase activation plus genetic loss-of-function with functional readout","pmids":["16061695"],"is_preprint":false},{"year":2005,"finding":"PAK1 phosphorylates SHARP (a Notch signaling co-repressor) at Ser3486 and Thr3568 within its repression domain; this interaction enhances SHARP-mediated repression of Notch target genes; inhibition of PAK1 or mutation of phosphorylation sites abolishes SHARP co-repressor function","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro phosphorylation with site mapping, reporter gene assay, PAK1 siRNA","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with phosphosite mapping plus mutagenesis plus reporter functional assay","pmids":["15824732"],"is_preprint":false},{"year":2006,"finding":"CRIPak is an endogenous PAK1 inhibitor that interacts with PAK1 through its N-terminal regulatory domain; CRIPak inhibits PAK1 kinase activity in vitro and in vivo, blocks PAK1-mediated LIMK activation and estrogen receptor transactivation; siRNA knockdown of CRIPak increases PAK1 activity and cytoskeletal remodeling","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, ER transactivation reporter","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with domain mapping and genetic loss-of-function","pmids":["16278681"],"is_preprint":false},{"year":2006,"finding":"PAK1 resides in a complex with atypical PKCζ and myosin II-B in an EGF-dependent manner; PAK1 is involved in aPKCζ phosphorylation, and aPKCζ in turn directly phosphorylates myosin II-B on a specific serine residue, leading to slower filament assembly of myosin II-B isoform specifically","method":"Co-immunoprecipitation, in vitro kinase assay, dominant-negative/knockdown experiments, myosin II-B filament assembly assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with isoform specificity demonstrated, reciprocal Co-IP","pmids":["16611744"],"is_preprint":false},{"year":2007,"finding":"Autophosphorylation of PAK1 triggered by Rho-family GTPase Chp leads to PAK1 ubiquitination and proteasomal degradation; Chp-induced degradation requires the PAK1 p21-binding domain, kinase activity, and autophosphorylation sites, but not PIX- or Nck-binding sites; Chp provides a function distinct from kinase activation to trigger PAK1 degradation","method":"Overexpression, ubiquitination assay, proteasome inhibitor treatment, domain mapping with deletion mutants, functional cell migration assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — mechanistic dissection of ubiquitin-proteasome degradation with domain mapping and kinase-dead controls","pmids":["17355222"],"is_preprint":false},{"year":2004,"finding":"Adhesion stimulates a direct physical association between PAK1 and ERK1/2; far-western analysis shows direct protein-protein interaction; peptide mapping identifies an ERK2-binding site within the PAK1 autoinhibitory domain; ERK2 phosphorylates PAK1 at Thr212 in vitro and in smooth muscle cells in an adhesion- and MEK/ERK-dependent manner; PAK-T212E phosphomimetic attenuates downstream ERK signaling, suggesting negative feedback","method":"Co-immunoprecipitation, far-western blotting, in vitro kinase assay, peptide mapping, phosphomimetic mutagenesis, reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with phosphosite mapping plus far-western direct interaction plus functional reporter","pmids":["15542607"],"is_preprint":false},{"year":2008,"finding":"Pak1 depletion by siRNA interferes with heregulin-mediated dephosphorylation of cofilin and lamellipodial protrusion; Pak1 depletion decreases phospho-MLC levels whereas Pak2 depletion increases them, demonstrating isoform-specific opposite roles in MLC phosphorylation and focal adhesion maturation","method":"siRNA knockdown, western blot for cofilin and MLC phosphorylation, focal adhesion immunofluorescence, invasion assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — isoform-specific siRNA with multiple molecular readouts","pmids":["18411304"],"is_preprint":false},{"year":2008,"finding":"PAK1 directly interacts with dynein light chain LC8 via residues 212-222; NMR and crystallographic studies show PAK1 binds along the same groove as canonical LC8 partners but with a distinct hydrogen-bond network; LC8 binding interface requires LC8 dimerization and precludes phosphorylation of LC8 at Ser88; in vitro phosphorylation assays show activated PAK1 fails to phosphorylate LC8","method":"X-ray crystallography, NMR, in vitro phosphorylation assay, LC8 point mutagenesis, biochemical binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus NMR plus in vitro kinase assay with mutagenesis","pmids":["18650427"],"is_preprint":false},{"year":2009,"finding":"A FRET-based conformational biosensor reveals PAK1 acquires an intermediate semi-open conformational state upon recruitment to the plasma membrane, selectively autophosphorylated on N-terminal serines but not Thr423; this intermediate is hypersensitive to Cdc42/Rac1 stimulation; PIX proteins contribute to PAK1 stimulation at membrane protrusions in a GTPase-independent way; trans-phosphorylation events occur between PAK1 molecules at the membrane","method":"FRET biosensor, live-cell imaging, pharmacological and genetic perturbations","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — FRET biosensor with spatiotemporal resolution, multiple mechanistic insights validated in live cells","pmids":["19574218"],"is_preprint":false},{"year":2010,"finding":"FOXO transcription factors directly regulate PAK1 gene expression as a transcriptional target; PAK1 acts locally in neuronal processes to induce polarity; knockdown of PAK1 phenocopies FOXO knockdown on neuronal polarity; exogenous PAK1 expression rescues polarity defects caused by FOXO knockdown in neurons in vivo","method":"Chromatin immunoprecipitation, shRNA knockdown, in vivo rescue experiments in rat cerebellar cortex, neuronal morphology analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — direct transcriptional target identification plus genetic epistasis with in vivo rescue","pmids":["20395366"],"is_preprint":false},{"year":2011,"finding":"PAK1 is required for second/sustained-phase insulin secretion in pancreatic β-cells; PAK1 activation is Cdc42-dependent and signals downstream to activate ERK1/2; PAK1 knockout mice show whole-body glucose intolerance and peripheral insulin resistance; in skeletal muscle, PAK1 loss causes defective cofilin phosphorylation and impaired GLUT4 translocation","method":"PAK1 knockout mice, islet isolation and insulin secretion assay, glucose tolerance testing, GLUT4 translocation assay, western blot for ERK and cofilin phosphorylation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean KO model with multiple defined molecular and functional readouts, human islet validation","pmids":["21969371"],"is_preprint":false},{"year":2012,"finding":"CYK4 (part of the centralspindlin complex) acts as a GAP for Rac1 and inhibits Rac1-dependent PAK1 and ARHGEF7 effector pathways at the cell equator during cytokinesis; CYK4 GAP mutants show elevated PAK1 activity and defects in cytokinesis that are rescued by depletion of PAK1 or ARHGEF7","method":"GAP mutant expression, Rac1 activity assay, PAK1/ARHGEF7 depletion rescue, immunofluorescence, cytokinesis phenotype scoring","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with rescue experiment and defined molecular pathway","pmids":["22945935"],"is_preprint":false},{"year":2013,"finding":"PAK1 can promote ERK/MEK activation in a kinase-independent manner; kinase-dead PAK1 overexpression increases MEK1/2 and ERK phosphorylation without affecting B-RAF or C-RAF Ser338 phosphorylation; activated Rac1 induces formation of a triple complex of Rac1, PAK1, and MEK1 independently of PAK1 kinase activity, suggesting a scaffold function for C-RAF interactions","method":"Kinase-dead PAK1 overexpression, western blot for downstream phosphorylation, co-immunoprecipitation of Rac1-PAK1-MEK1 complex","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistically novel scaffold finding, single lab with co-IP and kinase-dead controls","pmids":["23653349"],"is_preprint":false},{"year":2013,"finding":"HIV Nef recruits Pak1 and Pak2 to phosphorylate paxillin differentially: Pak1 phosphorylates paxillin at Ser258, which inhibits TACE/ADAM17 association and lipid raft transfer; Pak2 phosphorylates paxillin at Ser272/274 to induce TACE-paxillin association and extracellular vesicle shuttling","method":"Co-immunoprecipitation, site-specific phosphorylation mapping, extracellular vesicle fractionation, site-directed mutagenesis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — site-specific phosphorylation mapping with mutagenesis establishing distinct functions of PAK1 vs PAK2","pmids":["23317503"],"is_preprint":false},{"year":2014,"finding":"A TrioGEF-Rac1-PAK1 signaling axis drives invadopodia disassembly; Rac1 FRET biosensor shows Rac1 activity is excluded from invadopodia cores and activated during disassembly; PAK1 downstream of Rac1 phosphorylates cortactin, causing invadopodia dissolution","method":"FRET biosensor, photoactivatable Rac1, pharmacological and genetic inhibition, cortactin phosphorylation analysis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — FRET biosensor plus photoactivation plus epistasis defining Trio-Rac1-PAK1-cortactin pathway","pmids":["24859002"],"is_preprint":false},{"year":2014,"finding":"PAK1 inhibits nuclear translocation of Stat5 downstream of a FAK/Tiam1/Rac1/PAK1 pathway in FLT3- and KIT-driven leukemia cells; PAK1 inhibition prolongs survival of leukemic mice by blocking Stat5 nuclear translocation","method":"Pharmacological inhibition, shRNA knockdown, nuclear fractionation, mouse leukemia model survival analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — defined pathway with in vivo rescue, single lab","pmids":["25456130"],"is_preprint":false},{"year":2014,"finding":"JAK2 kinase phosphorylates PAK1 on tyrosine residues in response to irradiation, which is essential for PAK1 protein stability and binding to Snail; this JAK2-PAK1-Snail pathway promotes EMT and radioresistance in lung cancer cells","method":"JAK2 inhibitor treatment, co-immunoprecipitation, phosphorylation western blot, PAK1 stability assay, EMT marker analysis, xenograft model","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP with kinase inhibitor showing phosphorylation-dependent stability and Snail binding, single lab","pmids":["25125660"],"is_preprint":false},{"year":2014,"finding":"Pak1 is required for ventricular Ca2+ homeostasis; cardiomyocyte-specific Pak1 deletion causes ventricular arrhythmias during β-adrenergic stress; Pak1 regulates SERCA2a expression through a transcriptional mechanism involving serum response factor (SRF); constitutively active Pak1 increases SERCA2a mRNA and protein","method":"Conditional cardiac Pak1 knockout, adenoviral overexpression, calcium imaging, electrophysiology, SERCA2a western blot and qPCR, SRF pathway analysis","journal":"Circulation. Arrhythmia and electrophysiology","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific knockout with mechanistic transcriptional pathway and multiple functional readouts","pmids":["25217043"],"is_preprint":false},{"year":2015,"finding":"CK2α-interacting protein CKIP-1 mediates interaction between CK2α and PAK1 at membrane ruffles in a PI3K-dependent manner; PAK1 phosphorylation at Ser-223 by CK2 requires CKIP-1; PAK1 mediates phosphorylation of p41-Arc at the plasma membrane requiring PI3K and CKIP-1; CKIP-1 knockdown suppresses PAK1-mediated cell migration and invasion","method":"Co-immunoprecipitation, phosphorylation assays, siRNA knockdown, PI3K inhibition, cell migration/invasion assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — novel activation mechanism with Co-IP and functional validation, single lab","pmids":["26160174"],"is_preprint":false},{"year":2016,"finding":"GIT1/βPIX signaling proteins form complexes with γ-tubulin and PAK1 at centrosomes; depletion of PAK1 or inhibition of its kinase activity reduces microtubule nucleation from interphase centrosomes; in vitro kinase assays show GIT1 and βPIX (but not γ-tubulin) are PAK1 substrates; direct interaction of γ-tubulin with βPIX C-terminal domain and GIT1 N-terminal domain was demonstrated by pulldown","method":"Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, microtubule regrowth assay, phenotypic rescue, pulldown","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay plus pulldown plus functional microtubule regrowth assay","pmids":["27012601"],"is_preprint":false},{"year":2017,"finding":"p27Kip1 promotes interaction of Cortactin with PAK1; PAK1 phosphorylates Cortactin to promote invadopodia turnover; Cortactin mutants at PAK1-targeted phosphorylation sites abolish p27's effect on invadopodia dynamics; in absence of p27, impaired PAK1-Cortactin interaction leads to increased invadopodia stability","method":"Co-immunoprecipitation, phospho-mutant expression, invadopodia dynamics assay, invasion assay, Rac1 pathway analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus phospho-mutant functional rescue defining PAK1-Cortactin pathway","pmids":["28287395"],"is_preprint":false},{"year":2018,"finding":"De novo PAK1 mutations (Y131C, Y429C) reduce PAK1 dimerization as shown by co-immunoprecipitation and size-exclusion chromatography; reduced dimerization correlates with gain-of-function kinase activity; patient fibroblasts show enhanced phosphorylation of JNK, AKT, and c-JUN; PAK1 inhibitor FRAX486 reverses the filopodia-enriched cellular phenotype","method":"Co-immunoprecipitation, size-exclusion chromatography, phosphorylation western blot, cell spreading assay, PAK1 inhibitor rescue","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods demonstrating gain-of-function mechanism through impaired dimerization","pmids":["30290153"],"is_preprint":false},{"year":2018,"finding":"RIT1 directly interacts with PAK1 as a novel effector; RIT1 also directly interacts with CDC42 and RAC1 independently of guanine nucleotide binding; the RIT1-PAK1 complex regulates actin cytoskeletal rearrangements (stress fiber dissolution, focal adhesion reduction); disease-causing RIT1 mutations enhance PAK1, CDC42, and RAC1 interactions; kinase-dead PAK1 prevents RIT1-mediated cytoskeletal effects","method":"Pulldown with purified recombinant proteins, co-immunoprecipitation, heterologous expression, cell morphology analysis, migration assay, kinase-dead rescue","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with purified proteins plus functional rescue with kinase-dead PAK1","pmids":["29734338"],"is_preprint":false},{"year":2018,"finding":"PAK1 loss in atrial myocytes increases Rac1 membrane translocation, enhances NOX2-dependent ROS production, and exaggerates AngII-induced intracellular Ca2+ increase leading to arrhythmic events via NCX activity; PAK1 stimulation (FTY720) attenuates NCX-dependent Ca2+ overload by suppressing NOX2-dependent ROS","method":"PAK1 knockout mice, AngII stimulation, NOX2 inhibitors, NCX inhibitors, Ca2+ imaging, electrophysiology, ROS measurement","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with pharmacological pathway dissection and multiple molecular readouts","pmids":["29625277"],"is_preprint":false},{"year":2020,"finding":"Hypoxia induces ELP3-mediated acetylation of PAK1 at K420, which suppresses PAK1 dimerization and enhances kinase activity; activated PAK1 phosphorylates ATG5 at T101, protecting it from ubiquitin-dependent degradation and increasing affinity of the ATG12-ATG5 complex for ATG16L1, promoting autophagosome formation; SIRT1-mediated deacetylation of PAK1 at K420 opposes this pathway","method":"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, ubiquitination assay, autophagy flux assay, shRNA knockdown, inhibitor studies","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with site-specific mutagenesis of acetylation and phosphorylation sites, writer/eraser identified","pmids":["32186433"],"is_preprint":false},{"year":2021,"finding":"PP1A serves as the phosphatase in Smad4-mediated dephosphorylation of PAK1-T423; MYO18A acts as the PP1-interacting protein for substrate recognition; the Smad4-MYO18A-PP1A complex dephosphorylates PAK1-T423, thereby inhibiting PAK1-mediated β-catenin Ser675 phosphorylation and its nuclear translocation in cholangiocarcinoma","method":"LC-MS/MS, co-immunoprecipitation, in vitro phosphatase assay, domain mapping (RVFFR motif, CC domain), β-catenin localization, cell proliferation/invasion assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1–2 — LC-MS/MS substrate identification plus in vitro phosphatase assay plus domain mapping","pmids":["34799729"],"is_preprint":false},{"year":2021,"finding":"PAK1 promotes oligodendrocyte morphologic change and myelin production; inhibiting PAK1 early in oligodendrocyte development decreases morphologic complexity and alters F-actin spreading; constitutively activating AKT increases PAK1 expression; constitutively active PAK1 in zebrafish increases myelin internode length while PAK1 inhibition decreases it","method":"In vitro oligodendrocyte culture, PAK1 inhibitor treatment, constitutively active PAK1 expression in zebrafish, F-actin imaging, myelin internode measurement","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo model with functional readouts, single lab","pmids":["33478987"],"is_preprint":false},{"year":2022,"finding":"Skeletal muscle PAK1 is required for insulin-stimulated GLUT4 vesicle translocation via a non-canonical pathway involving downstream effector ARPC1B; inducible skeletal muscle-specific PAK1 knockout impairs whole-body glucose homeostasis; PAK1-enriched muscle conditioned media enhances β-cell function, revealing tissue crosstalk","method":"Inducible muscle-specific knockout and overexpression mouse models, glucose/insulin tolerance testing, GLUT4-myc translocation assay, conditioned media experiments","journal":"Frontiers in endocrinology","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific inducible KO/OE with multiple functional readouts and mechanistic pathway identification","pmids":["35222279"],"is_preprint":false},{"year":2022,"finding":"A PAK1-selective PROTAC degrader (BJG-05-039) using NVS-PAK1-1 allosteric inhibitor conjugated to lenalidomide induces selective PAK1 degradation via Cereblon E3 ubiquitin ligase; selective PAK1 degradation shows enhanced anti-proliferative effects relative to catalytic inhibition in PAK1-dependent but not PAK2-dependent cell lines","method":"PROTAC synthesis, protein degradation assay, anti-proliferation assay in PAK1 vs PAK2-dependent cell lines","journal":"Journal of medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — selective degrader tool demonstrating PAK1-specific dependency, single study","pmids":["36416208"],"is_preprint":false},{"year":2023,"finding":"Mechanical stress from fibrotic scarring induces PAK1-dependent nuclear softening and loss of H3K9Me3 heterochromatin repression; genetic loss of PAK1-dependent signaling impairs the mechanoadaptive response in vitro and dramatically improves fibrosis in liver and lung in vivo; PAK1 regulates actomyosin-dependent chromatin remodeling in myofibroblasts","method":"Genetic PAK1 manipulation, chromatin accessibility profiling (ATAC-seq), RNA-seq, nuclear mechanics assays, mouse liver and lung fibrosis models","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — genetic manipulation with multi-omic readouts in vivo, single lab","pmids":["37967011"],"is_preprint":false},{"year":1998,"finding":"PAK1 is rapidly activated downstream of TCR signaling in a Lck-, Vav-, and Cdc42-dependent manner and associates with tyrosine-phosphorylated Nck; dominant-negative PAK1 or Nck specifically inhibits TCR-mediated NFAT activation and ERK2 activation but not JNK activation, placing Pak1 in a JNK-independent pathway for gene expression","method":"Co-immunoprecipitation, kinase activity assay, dominant-negative inhibition, NFAT and ERK reporter assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — epistasis with dominant-negative constructs and specific reporter assays defining pathway position","pmids":["9755165"],"is_preprint":false},{"year":2021,"finding":"Fibrinogen activates PAK1 (phosphorylation) via syndecan-1, which in turn activates (dephosphorylates) cofilin, leading to disassembly of stress fibers and reduction of endothelial permeability; PAK1 silencing prevents fibrinogen-induced cofilin dephosphorylation and barrier protection","method":"Western blot for PAK1 and cofilin phosphorylation, siRNA knockdown, FITC-dextran permeability assay, in vivo hemorrhagic shock model","journal":"Shock","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA loss-of-function with defined molecular and functional readout, in vivo confirmation","pmids":["32433215"],"is_preprint":false}],"current_model":"PAK1 is a serine/threonine kinase activated by GTP-bound Rac1/Cdc42 (or by PI3K, CIB1, CK2/CKIP-1, ELP3-mediated acetylation, or Etk/Bmx tyrosine phosphorylation) that, upon release from autoinhibitory homodimerization, phosphorylates a defined set of substrates—including LIM-kinase (Thr508), cofilin, Raf-1 (Ser338), MEK1 (Ser298), myosin light chain, cortactin, ATG5 (Thr101), SHARP, cardiac troponin I, and paxillin—to regulate actin and microtubule cytoskeletal dynamics, cell migration, invadopodia turnover, MAPK/ERK cascade activation (also via a kinase-independent scaffold function), Notch and autophagy signaling, GLUT4 translocation, SERCA2a-dependent cardiac Ca2+ homeostasis, and nuclear mechanotransduction in fibroblasts, while being negatively regulated by PP1A-mediated dephosphorylation of Thr423, CRIPak binding, Cdc42/Chp-induced autophosphorylation-dependent proteasomal degradation, and FOXO-driven transcriptional suppression."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing PAK1 as a kinase effector downstream of Rac/Cdc42 GTPases that activates stress-activated MAP kinase pathways answered the fundamental question of how Rho-family GTPase signals reach p38 and JNK cascades.","evidence":"Dominant-negative PAK1 blocks Rac/Cdc42- and IL-1-induced p38 activation in co-expression assays","pmids":["7592586"],"confidence":"High","gaps":["Direct phosphorylation of MAP3K intermediates not shown","Upstream mechanism of PAK1 activation not yet defined"]},{"year":1996,"claim":"Identification of the Nck adapter as a direct PAK1-binding partner via SH3-domain interactions revealed how receptor tyrosine kinase signaling (e.g., PDGFR) recruits PAK1 to signaling complexes.","evidence":"Reciprocal co-IP and in vitro binding with domain mapping of Nck SH3-2 and PAK1 proline-rich motif","pmids":["8824201"],"confidence":"High","gaps":["Functional consequence of Nck-mediated PAK1 recruitment not yet demonstrated"]},{"year":1997,"claim":"Demonstrating that activated PAK1 directly reorganizes the actin cytoskeleton—inducing filopodia and membrane ruffles—and localizes to F-actin-rich structures established PAK1 as a direct cytoskeletal effector rather than merely a kinase cascade component.","evidence":"Microinjection of activated PAK1, immunofluorescence co-localization with F-actin, co-IP with filamentous actin, pharmacological inhibitor studies","pmids":["9395435","9298982"],"confidence":"High","gaps":["Direct actin-binding substrates not yet identified","Kinase-dependent vs. kinase-independent cytoskeletal effects not resolved"]},{"year":1998,"claim":"Placing PAK1 in TCR signaling downstream of Lck/Vav/Cdc42 and upstream of NFAT and ERK2 (but not JNK) demonstrated PAK1 functions in immune cell gene expression beyond stress kinase cascades.","evidence":"Dominant-negative PAK1 blocks NFAT and ERK2 reporters in T cells; co-IP with phospho-Nck after TCR stimulation","pmids":["9755165"],"confidence":"High","gaps":["Direct substrates mediating NFAT activation not identified"]},{"year":1999,"claim":"Identification of LIM-kinase Thr508 and myosin light chain as direct PAK1 substrates connected PAK1 activity to specific molecular steps in actin depolymerization and directed cell motility.","evidence":"In vitro kinase assay with mutagenesis for LIMK Thr508; inducible expression of kinase-dead/active PAK1 with MLC phosphorylation and chemotaxis readouts","pmids":["10559936","10330410"],"confidence":"High","gaps":["Whether PAK1 phosphorylates MLC directly or through MLCK not fully resolved","Spatial regulation of substrate phosphorylation in vivo unclear"]},{"year":2001,"claim":"Discovery that PAK1 directly phosphorylates Raf-1 at Ser338 established PAK1 as a critical input for MAPK/ERK cascade activation independent of Ras-mediated Raf recruitment.","evidence":"Co-IP of endogenous PAK1–Raf-1 complex, in vitro kinase assay showing Ser338 phosphorylation, domain mapping","pmids":["11733498"],"confidence":"High","gaps":["Relative contribution of PAK1 vs. other Raf-1 Ser338 kinases in vivo unknown"]},{"year":2002,"claim":"Showing that PI3K binds and activates PAK1 independently of Cdc42/Rac1 revealed a second, GTPase-independent activation route and direct actin phosphorylation as a mechanism for stress fiber dissolution.","evidence":"Co-IP with domain mapping, in vitro kinase assay on actin, kinase-dead control","pmids":["12181358"],"confidence":"High","gaps":["Physiological relevance of direct actin phosphorylation needs in vivo confirmation","Actin phosphorylation site not mapped"]},{"year":2003,"claim":"Multiple discoveries expanded PAK1's interaction network: cardiac localization with PP2A and troponin I regulation, EGFR-Grb2-mediated recruitment to membranes, and Cdk5-mediated Thr212 phosphorylation in neurons broadened PAK1 function to cardiac contractility and neuronal development.","evidence":"Co-IP in cardiac myocytes with Ca²⁺-tension measurements; Grb2 binding via SH3 domain with TAT-peptide competition; phospho-specific antibody in embryonic brain","pmids":["14670848","12522133","12950086"],"confidence":"High","gaps":["Direct troponin I phosphatase mechanism downstream of PAK1-PP2A unclear","Functional consequence of Thr212 phosphorylation in neurons not shown"]},{"year":2004,"claim":"Demonstration that ERK2 phosphorylates PAK1 at Thr212 in an adhesion-dependent manner, with the phosphomimetic attenuating ERK signaling, established a negative feedback loop between PAK1 and the ERK pathway.","evidence":"Far-western confirming direct interaction, in vitro kinase assay with site mapping, phosphomimetic reporter assay","pmids":["15542607"],"confidence":"High","gaps":["In vivo significance of feedback loop not tested genetically"]},{"year":2005,"claim":"Crystal structures at 1.8 Å resolution revealing that the PAK1 kinase domain adopts a near-active conformation even without Thr423 phosphorylation fundamentally reframed the activation model: autoinhibitory dimerization, not activation-loop phosphorylation, is the primary constraint on activity.","evidence":"X-ray crystallography of free and phosphomimetic kinase domains","pmids":["15893667"],"confidence":"High","gaps":["Full-length PAK1 dimer structure not solved","Dynamics of dimer-to-monomer transition not captured"]},{"year":2005,"claim":"Identification of CIB1 as a calcium-dependent PAK1 activator and CRIPak as an endogenous PAK1 inhibitor defined two new regulatory inputs controlling PAK1 kinase output and its downstream effects on LIMK/cofilin.","evidence":"In vitro kinase activation by CIB1, siRNA depletion reducing adhesion-induced PAK1 activation; CRIPak Co-IP and in vitro kinase inhibition with siRNA derepression","pmids":["16061695","16278681"],"confidence":"High","gaps":["CIB1 and CRIPak binding sites on PAK1 not precisely mapped structurally","In vivo physiological contexts for CIB1/CRIPak regulation not established"]},{"year":2007,"claim":"Demonstration that Chp GTPase triggers PAK1 autophosphorylation-dependent ubiquitination and proteasomal degradation revealed a turnover mechanism distinct from kinase activation, explaining how cells reset PAK1 signaling.","evidence":"Ubiquitination assay with proteasome inhibitor, domain mapping with kinase-dead and autophosphorylation-site mutants","pmids":["17355222"],"confidence":"High","gaps":["E3 ubiquitin ligase identity not determined","Physiological trigger for Chp-mediated PAK1 degradation unclear"]},{"year":2009,"claim":"A FRET-based conformational biosensor revealed that PAK1 adopts an intermediate semi-open state at the plasma membrane, selectively autophosphorylated on N-terminal serines, providing the first real-time visualization of spatially regulated PAK1 activation dynamics.","evidence":"FRET biosensor in live cells with pharmacological and genetic perturbations","pmids":["19574218"],"confidence":"High","gaps":["Structural basis of semi-open intermediate not resolved","Whether intermediate state exists for other PAK family members unknown"]},{"year":2011,"claim":"PAK1 knockout mice revealed essential roles in glucose homeostasis: PAK1 is required for sustained insulin secretion from β-cells and for GLUT4 translocation in skeletal muscle via cofilin phosphorylation, linking cytoskeletal kinase function to metabolic regulation.","evidence":"Global PAK1 KO with glucose tolerance testing, islet insulin secretion, GLUT4 translocation, and ERK/cofilin phosphorylation readouts","pmids":["21969371"],"confidence":"High","gaps":["Tissue-specific contributions not dissected in this global KO","Direct PAK1 substrates in β-cell exocytosis not identified"]},{"year":2013,"claim":"Discovery that kinase-dead PAK1 still promotes MEK/ERK activation by scaffolding a Rac1–PAK1–MEK1 complex established a kinase-independent mechanism for MAPK pathway engagement, broadening PAK1's signaling repertoire beyond its catalytic activity.","evidence":"Kinase-dead PAK1 overexpression increases MEK/ERK phosphorylation; co-IP of Rac1-PAK1-MEK1 triple complex","pmids":["23653349"],"confidence":"Medium","gaps":["Scaffold function not yet shown with endogenous protein levels","Structural basis of scaffold interaction unknown","Single-lab finding"]},{"year":2014,"claim":"Multiple studies defined PAK1 as an effector in invadopodia dynamics (phosphorylating cortactin downstream of Trio-Rac1), cardiac physiology (regulating SERCA2a via SRF transcription in cardiomyocytes), and as a paxillin Ser258 kinase in HIV Nef-mediated vesicle trafficking.","evidence":"FRET/photoactivation for invadopodia; conditional cardiac KO with Ca²⁺ imaging and SERCA2a qPCR; site-specific phospho-mapping of paxillin with mutagenesis","pmids":["24859002","25217043","23317503"],"confidence":"High","gaps":["How PAK1-cortactin phosphorylation triggers disassembly structurally undefined","SRF cofactor mediating PAK1 transcriptional effect not identified"]},{"year":2018,"claim":"Patient mutations (Y131C, Y429C) that reduce PAK1 dimerization cause constitutive kinase activation, linking the autoinhibitory dimer model to human neurodevelopmental disease and validating dimerization as the primary restraint on PAK1 activity in vivo.","evidence":"Co-IP and SEC showing reduced dimerization, enhanced JNK/AKT phosphorylation in patient fibroblasts, rescue by PAK1 inhibitor FRAX486","pmids":["30290153"],"confidence":"High","gaps":["Full spectrum of downstream targets dysregulated by gain-of-function mutations not catalogued","Neuronal-specific pathomechanism not dissected"]},{"year":2020,"claim":"Identification of ELP3-mediated acetylation at K420 as an activation switch that drives PAK1-dependent ATG5 Thr101 phosphorylation and autophagosome formation connected PAK1 to autophagy regulation via a hypoxia-responsive post-translational code.","evidence":"In vitro kinase assay, K420 acetylation/deacetylation mutagenesis, ubiquitination assay for ATG5, autophagy flux measurement","pmids":["32186433"],"confidence":"High","gaps":["In vivo relevance of ELP3-PAK1-ATG5 axis in tissue-specific autophagy not tested","Whether SIRT1-mediated deacetylation is the sole eraser unknown"]},{"year":2021,"claim":"Identification of the Smad4-MYO18A-PP1A complex as the phosphatase targeting PAK1-Thr423 resolved how PAK1 activity is terminated and connected PAK1 inactivation to suppression of β-catenin nuclear translocation.","evidence":"LC-MS/MS identification, in vitro phosphatase assay, domain mapping of RVFFR motif, β-catenin localization in cholangiocarcinoma cells","pmids":["34799729"],"confidence":"High","gaps":["Whether this phosphatase complex operates in tissues beyond cholangiocarcinoma not tested","Other PAK1 phosphatases may exist"]},{"year":2022,"claim":"Inducible skeletal-muscle-specific PAK1 knockout confirmed a non-redundant role in GLUT4 translocation via ARPC1B and revealed muscle-to-β-cell crosstalk through secreted factors, establishing PAK1 as a systemic metabolic regulator.","evidence":"Inducible muscle-specific KO/OE mice, glucose/insulin tolerance, GLUT4-myc translocation, conditioned media on β-cells","pmids":["35222279"],"confidence":"High","gaps":["Identity of PAK1-dependent myokines unknown","ARPC1B phosphorylation site not mapped"]},{"year":2023,"claim":"Demonstration that PAK1 drives nuclear softening and H3K9Me3 heterochromatin loss in mechanically stressed fibroblasts, with PAK1 loss improving fibrosis in vivo, revealed a nuclear mechanotransduction function beyond its classical cytoplasmic roles.","evidence":"Genetic PAK1 manipulation with ATAC-seq, RNA-seq, nuclear mechanics, mouse liver/lung fibrosis models","pmids":["37967011"],"confidence":"Medium","gaps":["Direct nuclear substrates of PAK1 mediating chromatin remodeling not identified","Whether PAK1 translocates to the nucleus or acts through cytoplasmic intermediaries unclear","Single-lab finding"]},{"year":null,"claim":"Key unresolved questions include the full-length autoinhibitory dimer structure, the identity of the E3 ligase(s) mediating PAK1 ubiquitination, the direct nuclear substrates through which PAK1 remodels chromatin, and the identity of PAK1-dependent myokines mediating muscle-to-islet crosstalk.","evidence":"","pmids":[],"confidence":"Low","gaps":["Full-length PAK1 dimer crystal structure not available","E3 ubiquitin ligase for Chp-induced PAK1 degradation unknown","Nuclear mechanotransduction substrates not identified","Myokine identity downstream of muscle PAK1 undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,5,7,8,14,26,27,33,37]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[4,2,5]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[25]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,6,21]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[2,4,5,6]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[32]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6,9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,7,18,25,43]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[6,10]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[37]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[24]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[17,38]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[23,40]}],"complexes":["PAK1 autoinhibitory homodimer"],"partners":["RAC1","CDC42","NCK1","LIMK1","RAF1","GRB2","ARHGEF7","CIB1"],"other_free_text":[]},"mechanistic_narrative":"PAK1 is a Rac1/Cdc42-activated serine/threonine kinase that serves as a central integrator of cytoskeletal dynamics, MAPK signaling, and diverse tissue-specific physiological processes. Upon release from its autoinhibitory homodimer—whose crystal structure reveals an intermediate-active kinase domain conformation even without Thr423 phosphorylation—PAK1 phosphorylates LIM-kinase (Thr508), myosin light chain, cortactin, Raf-1 (Ser338), ATG5 (Thr101), SHARP, and paxillin to control actin remodeling, directed cell migration, invadopodia turnover, ERK cascade activation (including a kinase-independent scaffold function bridging Rac1 to MEK1), Notch target gene repression, and autophagosome formation [PMID:10559936, PMID:10330410, PMID:11733498, PMID:24859002, PMID:32186433, PMID:15824732, PMID:23653349]. Beyond cytoskeletal regulation, PAK1 is essential for insulin-stimulated GLUT4 translocation in skeletal muscle, SERCA2a-dependent cardiac Ca²⁺ homeostasis, oligodendrocyte myelination, nuclear mechanotransduction in fibroblasts, and NFAT activation downstream of the T-cell receptor [PMID:35222279, PMID:25217043, PMID:33478987, PMID:37967011, PMID:9755165]. De novo gain-of-function PAK1 mutations (Y131C, Y429C) that impair autoinhibitory dimerization cause a neurodevelopmental disorder with enhanced JNK/AKT signaling [PMID:30290153]."},"prefetch_data":{"uniprot":{"accession":"Q13153","full_name":"Serine/threonine-protein kinase PAK 1","aliases":["Alpha-PAK","p21-activated kinase 1","PAK-1","p65-PAK"],"length_aa":545,"mass_kda":60.6,"function":"Protein kinase involved in intracellular signaling pathways downstream of integrins and receptor-type kinases that plays an important role in cytoskeleton dynamics, in cell adhesion, migration, proliferation, apoptosis, mitosis, and in vesicle-mediated transport processes (PubMed:10551809, PubMed:11896197, PubMed:12876277, PubMed:14585966, PubMed:15611088, PubMed:17726028, PubMed:17989089, PubMed:30290153, PubMed:17420447). Can directly phosphorylate BAD and protects cells against apoptosis (By similarity). Activated by interaction with CDC42 and RAC1 (PubMed:8805275, PubMed:9528787). Functions as a GTPase effector that links the Rho-related GTPases CDC42 and RAC1 to the JNK MAP kinase pathway (PubMed:8805275, PubMed:9528787). Phosphorylates and activates MAP2K1, and thereby mediates activation of downstream MAP kinases (By similarity). Involved in the reorganization of the actin cytoskeleton, actin stress fibers and of focal adhesion complexes (PubMed:9032240, PubMed:9395435). Phosphorylates the tubulin chaperone TBCB and thereby plays a role in the regulation of microtubule biogenesis and organization of the tubulin cytoskeleton (PubMed:15831477). Plays a role in the regulation of insulin secretion in response to elevated glucose levels (PubMed:22669945). Part of a ternary complex that contains PAK1, DVL1 and MUSK that is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ) (By similarity). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2 (PubMed:12624090). Phosphorylates MYL9/MLC2 (By similarity). Phosphorylates RAF1 at 'Ser-338' and 'Ser-339' resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2 (PubMed:11733498). Phosphorylates SNAI1 at 'Ser-246' promoting its transcriptional repressor activity by increasing its accumulation in the nucleus (PubMed:15833848). In podocytes, promotes NR3C2 nuclear localization (By similarity). Required for atypical chemokine receptor ACKR2-induced phosphorylation of LIMK1 and cofilin (CFL1) and for the up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation (PubMed:23633677). In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3, maybe through CFL1 phosphorylation and inactivation (By similarity). Plays a role in RUFY3-mediated facilitating gastric cancer cells migration and invasion (PubMed:25766321). In response to DNA damage, phosphorylates MORC2 which activates its ATPase activity and facilitates chromatin remodeling (PubMed:23260667). In neurons, plays a crucial role in regulating GABA(A) receptor synaptic stability and hence GABAergic inhibitory synaptic transmission through its role in F-actin stabilization (By similarity). In hippocampal neurons, necessary for the formation of dendritic spines and excitatory synapses; this function is dependent on kinase activity and may be exerted by the regulation of actomyosin contractility through the phosphorylation of myosin II regulatory light chain (MLC) (By similarity). Along with GIT1, positively regulates microtubule nucleation during interphase (PubMed:27012601). Phosphorylates FXR1, promoting its localization to stress granules and activity (PubMed:20417602). Phosphorylates ILK on 'Thr-173' and 'Ser-246', promoting nuclear export of ILK (PubMed:17420447)","subcellular_location":"Cytoplasm; Cell junction, focal adhesion; Cell projection, lamellipodium; Cell membrane; Cell projection, ruffle membrane; Cell projection, invadopodium; Nucleus, nucleoplasm; Chromosome; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome","url":"https://www.uniprot.org/uniprotkb/Q13153/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAK1","classification":"Not Classified","n_dependent_lines":17,"n_total_lines":1208,"dependency_fraction":0.014072847682119206},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000149269","cell_line_id":"CID000541","localizations":[{"compartment":"focal_adhesions","grade":3},{"compartment":"cytoplasmic","grade":2}],"interactors":[{"gene":"GIT2","stoichiometry":10.0},{"gene":"ARHGEF7","stoichiometry":4.0},{"gene":"NCK2","stoichiometry":0.2},{"gene":"PAK3","stoichiometry":0.2},{"gene":"ARHGEF6","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000541","total_profiled":1310},"omim":[{"mim_id":"620862","title":"ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 52; ANKRD52","url":"https://www.omim.org/entry/620862"},{"mim_id":"620101","title":"RAS HOMOLOG FAMILY, MEMBER V; RHOV","url":"https://www.omim.org/entry/620101"},{"mim_id":"619309","title":"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1F; PPM1F","url":"https://www.omim.org/entry/619309"},{"mim_id":"619308","title":"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1E; PPM1E","url":"https://www.omim.org/entry/619308"},{"mim_id":"618825","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63","url":"https://www.omim.org/entry/618825"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":118.6}],"url":"https://www.proteinatlas.org/search/PAK1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q13153","domains":[{"cath_id":"3.30.200.20","chopping":"264-344","consensus_level":"high","plddt":91.1895,"start":264,"end":344},{"cath_id":"1.10.510.10","chopping":"349-543","consensus_level":"high","plddt":94.5919,"start":349,"end":543}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13153","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13153-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13153-F1-predicted_aligned_error_v6.png","plddt_mean":73.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAK1","jax_strain_url":"https://www.jax.org/strain/search?query=PAK1"},"sequence":{"accession":"Q13153","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13153.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13153/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13153"}},"corpus_meta":[{"pmid":"10559936","id":"PMC_10559936","title":"Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics.","date":"1999","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10559936","citation_count":862,"is_preprint":false},{"pmid":"7592586","id":"PMC_7592586","title":"Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7592586","citation_count":676,"is_preprint":false},{"pmid":"9395435","id":"PMC_9395435","title":"Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells.","date":"1997","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9395435","citation_count":609,"is_preprint":false},{"pmid":"10330410","id":"PMC_10330410","title":"p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts.","date":"1999","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10330410","citation_count":332,"is_preprint":false},{"pmid":"8824201","id":"PMC_8824201","title":"Interaction of the Nck adapter protein with p21-activated kinase (PAK1).","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8824201","citation_count":273,"is_preprint":false},{"pmid":"9298982","id":"PMC_9298982","title":"Localization of p21-activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells.","date":"1997","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9298982","citation_count":200,"is_preprint":false},{"pmid":"21482786","id":"PMC_21482786","title":"Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21482786","citation_count":172,"is_preprint":false},{"pmid":"32186433","id":"PMC_32186433","title":"Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.","date":"2020","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/32186433","citation_count":137,"is_preprint":false},{"pmid":"11134074","id":"PMC_11134074","title":"Temporal and spatial distribution of activated Pak1 in fibroblasts.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11134074","citation_count":137,"is_preprint":false},{"pmid":"24859002","id":"PMC_24859002","title":"A Trio-Rac1-Pak1 signalling axis drives invadopodia disassembly.","date":"2014","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24859002","citation_count":134,"is_preprint":false},{"pmid":"12748292","id":"PMC_12748292","title":"Yeast Pak1 kinase associates with and activates Snf1.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12748292","citation_count":124,"is_preprint":false},{"pmid":"17486065","id":"PMC_17486065","title":"Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17486065","citation_count":122,"is_preprint":false},{"pmid":"21969371","id":"PMC_21969371","title":"Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21969371","citation_count":117,"is_preprint":false},{"pmid":"12181358","id":"PMC_12181358","title":"Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12181358","citation_count":110,"is_preprint":false},{"pmid":"18411304","id":"PMC_18411304","title":"Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18411304","citation_count":108,"is_preprint":false},{"pmid":"14670848","id":"PMC_14670848","title":"Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes.","date":"2003","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/14670848","citation_count":107,"is_preprint":false},{"pmid":"11733498","id":"PMC_11733498","title":"Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11733498","citation_count":106,"is_preprint":false},{"pmid":"9755165","id":"PMC_9755165","title":"A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9755165","citation_count":105,"is_preprint":false},{"pmid":"33945512","id":"PMC_33945512","title":"DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33945512","citation_count":104,"is_preprint":false},{"pmid":"11382770","id":"PMC_11382770","title":"Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11382770","citation_count":97,"is_preprint":false},{"pmid":"22945935","id":"PMC_22945935","title":"CYK4 inhibits Rac1-dependent PAK1 and ARHGEF7 effector pathways during cytokinesis.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22945935","citation_count":90,"is_preprint":false},{"pmid":"16611744","id":"PMC_16611744","title":"PAK1 and aPKCzeta regulate myosin II-B phosphorylation: a novel signaling pathway regulating filament assembly.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16611744","citation_count":89,"is_preprint":false},{"pmid":"12522133","id":"PMC_12522133","title":"p21-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12522133","citation_count":87,"is_preprint":false},{"pmid":"23317503","id":"PMC_23317503","title":"HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23317503","citation_count":85,"is_preprint":false},{"pmid":"28055013","id":"PMC_28055013","title":"MicroRNA-494 inhibits breast cancer progression by directly targeting PAK1.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/28055013","citation_count":80,"is_preprint":false},{"pmid":"20395366","id":"PMC_20395366","title":"A FOXO-Pak1 transcriptional pathway controls neuronal polarity.","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20395366","citation_count":79,"is_preprint":false},{"pmid":"15893667","id":"PMC_15893667","title":"The active conformation of the PAK1 kinase domain.","date":"2005","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/15893667","citation_count":75,"is_preprint":false},{"pmid":"25125660","id":"PMC_25125660","title":"PAK1 tyrosine phosphorylation is required to induce epithelial-mesenchymal transition and radioresistance in lung cancer cells.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25125660","citation_count":74,"is_preprint":false},{"pmid":"28202661","id":"PMC_28202661","title":"Targeting PAK1.","date":"2017","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/28202661","citation_count":72,"is_preprint":false},{"pmid":"23535073","id":"PMC_23535073","title":"P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.","date":"2013","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/23535073","citation_count":72,"is_preprint":false},{"pmid":"16061695","id":"PMC_16061695","title":"Essential role of CIB1 in regulating PAK1 activation and cell migration.","date":"2005","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16061695","citation_count":71,"is_preprint":false},{"pmid":"20426825","id":"PMC_20426825","title":"Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20426825","citation_count":70,"is_preprint":false},{"pmid":"12719581","id":"PMC_12719581","title":"Role of the serine-threonine kinase PAK-1 in myxoma virus replication.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12719581","citation_count":70,"is_preprint":false},{"pmid":"15282344","id":"PMC_15282344","title":"PAK kinases Ste20 and Pak1 govern cell polarity at different stages of mating in Cryptococcus neoformans.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15282344","citation_count":69,"is_preprint":false},{"pmid":"32313880","id":"PMC_32313880","title":"PAK1-blockers: Potential Therapeutics against COVID-19.","date":"2020","source":"Medicine in drug discovery","url":"https://pubmed.ncbi.nlm.nih.gov/32313880","citation_count":69,"is_preprint":false},{"pmid":"23653349","id":"PMC_23653349","title":"p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23653349","citation_count":62,"is_preprint":false},{"pmid":"30290153","id":"PMC_30290153","title":"Activating Mutations in PAK1, Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental Disorder.","date":"2018","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30290153","citation_count":61,"is_preprint":false},{"pmid":"17443815","id":"PMC_17443815","title":"Pak1 regulates dendritic branching and spine formation.","date":"2007","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17443815","citation_count":58,"is_preprint":false},{"pmid":"24954107","id":"PMC_24954107","title":"miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.","date":"2014","source":"Urologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24954107","citation_count":57,"is_preprint":false},{"pmid":"25781190","id":"PMC_25781190","title":"miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy.","date":"2015","source":"Cardiovascular therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25781190","citation_count":56,"is_preprint":false},{"pmid":"15542607","id":"PMC_15542607","title":"Adhesion stimulates direct PAK1/ERK2 association and leads to ERK-dependent PAK1 Thr212 phosphorylation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15542607","citation_count":55,"is_preprint":false},{"pmid":"26170031","id":"PMC_26170031","title":"PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/26170031","citation_count":53,"is_preprint":false},{"pmid":"25456130","id":"PMC_25456130","title":"Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25456130","citation_count":51,"is_preprint":false},{"pmid":"25569743","id":"PMC_25569743","title":"Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.","date":"2015","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25569743","citation_count":50,"is_preprint":false},{"pmid":"25174975","id":"PMC_25174975","title":"Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer.","date":"2014","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25174975","citation_count":49,"is_preprint":false},{"pmid":"17355222","id":"PMC_17355222","title":"Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17355222","citation_count":49,"is_preprint":false},{"pmid":"25388666","id":"PMC_25388666","title":"Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.","date":"2014","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/25388666","citation_count":48,"is_preprint":false},{"pmid":"25074413","id":"PMC_25074413","title":"PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition.","date":"2014","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25074413","citation_count":47,"is_preprint":false},{"pmid":"26774265","id":"PMC_26774265","title":"FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26774265","citation_count":47,"is_preprint":false},{"pmid":"32272148","id":"PMC_32272148","title":"Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32272148","citation_count":46,"is_preprint":false},{"pmid":"25766321","id":"PMC_25766321","title":"PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25766321","citation_count":45,"is_preprint":false},{"pmid":"18649038","id":"PMC_18649038","title":"The Pak1 kinase: an important regulator of neuronal morphology and function in the developing forebrain.","date":"2008","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18649038","citation_count":45,"is_preprint":false},{"pmid":"22252525","id":"PMC_22252525","title":"PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation.","date":"2012","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22252525","citation_count":45,"is_preprint":false},{"pmid":"18650427","id":"PMC_18650427","title":"Biochemical and structural characterization of the Pak1-LC8 interaction.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18650427","citation_count":44,"is_preprint":false},{"pmid":"16278681","id":"PMC_16278681","title":"CRIPak, a novel endogenous Pak1 inhibitor.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16278681","citation_count":43,"is_preprint":false},{"pmid":"28287395","id":"PMC_28287395","title":"p27Kip1 promotes invadopodia turnover and invasion through the regulation of the PAK1/Cortactin pathway.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28287395","citation_count":43,"is_preprint":false},{"pmid":"37124926","id":"PMC_37124926","title":"Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK.","date":"2023","source":"Biophysical reviews","url":"https://pubmed.ncbi.nlm.nih.gov/37124926","citation_count":42,"is_preprint":false},{"pmid":"31857154","id":"PMC_31857154","title":"Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.","date":"2019","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/31857154","citation_count":42,"is_preprint":false},{"pmid":"30536654","id":"PMC_30536654","title":"microRNA-96 protects pancreatic β-cell function by targeting PAK1 in gestational diabetes mellitus.","date":"2018","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30536654","citation_count":41,"is_preprint":false},{"pmid":"27117533","id":"PMC_27117533","title":"P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer.","date":"2016","source":"Annals of oncology : official journal of the European Society for Medical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27117533","citation_count":40,"is_preprint":false},{"pmid":"34799729","id":"PMC_34799729","title":"The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34799729","citation_count":40,"is_preprint":false},{"pmid":"28574147","id":"PMC_28574147","title":"The p21-activated kinase 1 (Pak1) signalling pathway in cardiac disease: from mechanistic study to therapeutic exploration.","date":"2017","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28574147","citation_count":38,"is_preprint":false},{"pmid":"15824732","id":"PMC_15824732","title":"An essential role of Pak1 phosphorylation of SHARP in Notch signaling.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15824732","citation_count":38,"is_preprint":false},{"pmid":"27430434","id":"PMC_27430434","title":"microRNA-7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/27430434","citation_count":37,"is_preprint":false},{"pmid":"31504246","id":"PMC_31504246","title":"De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31504246","citation_count":37,"is_preprint":false},{"pmid":"19574218","id":"PMC_19574218","title":"Dissecting activation of the PAK1 kinase at protrusions in living cells.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19574218","citation_count":37,"is_preprint":false},{"pmid":"30863103","id":"PMC_30863103","title":"lncRNA MALAT1 potentiates the progression of tongue squamous cell carcinoma through regulating miR-140-5p-PAK1 pathway.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30863103","citation_count":36,"is_preprint":false},{"pmid":"15993754","id":"PMC_15993754","title":"PAK1 regulates myosin II-B phosphorylation, filament assembly, localization and cell chemotaxis.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/15993754","citation_count":35,"is_preprint":false},{"pmid":"24347489","id":"PMC_24347489","title":"Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24347489","citation_count":35,"is_preprint":false},{"pmid":"25217043","id":"PMC_25217043","title":"Pak1 is required to maintain ventricular Ca²⁺ homeostasis and electrophysiological stability through SERCA2a regulation in mice.","date":"2014","source":"Circulation. Arrhythmia and electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/25217043","citation_count":34,"is_preprint":false},{"pmid":"27939839","id":"PMC_27939839","title":"Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells.","date":"2016","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/27939839","citation_count":33,"is_preprint":false},{"pmid":"31071459","id":"PMC_31071459","title":"PAK1 promotes proliferation, migration and invasion of hepatocellular carcinoma by facilitating EMT via directly up-regulating Snail.","date":"2019","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/31071459","citation_count":32,"is_preprint":false},{"pmid":"16042564","id":"PMC_16042564","title":"Spatiotemporal regulation of the Pak1 kinase.","date":"2005","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16042564","citation_count":31,"is_preprint":false},{"pmid":"32855541","id":"PMC_32855541","title":"circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32855541","citation_count":31,"is_preprint":false},{"pmid":"31674013","id":"PMC_31674013","title":"MiR-142-3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31674013","citation_count":31,"is_preprint":false},{"pmid":"32322465","id":"PMC_32322465","title":"Identification of a novel PAK1 inhibitor to treat pancreatic cancer.","date":"2019","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/32322465","citation_count":30,"is_preprint":false},{"pmid":"33478987","id":"PMC_33478987","title":"PAK1 Positively Regulates Oligodendrocyte Morphology and Myelination.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33478987","citation_count":29,"is_preprint":false},{"pmid":"26043730","id":"PMC_26043730","title":"PAK1 regulates cortical development via promoting neuronal migration and progenitor cell proliferation.","date":"2015","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/26043730","citation_count":29,"is_preprint":false},{"pmid":"29734338","id":"PMC_29734338","title":"RIT1 controls actin dynamics via complex formation with RAC1/CDC42 and PAK1.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29734338","citation_count":28,"is_preprint":false},{"pmid":"34390849","id":"PMC_34390849","title":"p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.","date":"2021","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/34390849","citation_count":25,"is_preprint":false},{"pmid":"27012601","id":"PMC_27012601","title":"GIT1/βPIX signaling proteins and PAK1 kinase regulate microtubule nucleation.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27012601","citation_count":25,"is_preprint":false},{"pmid":"32421151","id":"PMC_32421151","title":"Fission yeast Pak1 phosphorylates anillin-like Mid1 for spatial control of cytokinesis.","date":"2020","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32421151","citation_count":25,"is_preprint":false},{"pmid":"32190006","id":"PMC_32190006","title":"MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32190006","citation_count":25,"is_preprint":false},{"pmid":"29625277","id":"PMC_29625277","title":"Loss of p21-activated kinase 1 (Pak1) promotes atrial arrhythmic activity.","date":"2018","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/29625277","citation_count":24,"is_preprint":false},{"pmid":"12950086","id":"PMC_12950086","title":"Pak1 and its T212 phosphorylated form accumulate in neurones and epithelial cells of the developing rodent.","date":"2003","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/12950086","citation_count":24,"is_preprint":false},{"pmid":"35222279","id":"PMC_35222279","title":"Changes in Skeletal Muscle PAK1 Levels Regulate Tissue Crosstalk to Impact Whole Body Glucose Homeostasis.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35222279","citation_count":22,"is_preprint":false},{"pmid":"38785043","id":"PMC_38785043","title":"Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.","date":"2024","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/38785043","citation_count":22,"is_preprint":false},{"pmid":"30442385","id":"PMC_30442385","title":"NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.","date":"2018","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30442385","citation_count":22,"is_preprint":false},{"pmid":"31516713","id":"PMC_31516713","title":"Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion.","date":"2019","source":"Pharmacology research & perspectives","url":"https://pubmed.ncbi.nlm.nih.gov/31516713","citation_count":21,"is_preprint":false},{"pmid":"37225681","id":"PMC_37225681","title":"The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1 modulation.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37225681","citation_count":20,"is_preprint":false},{"pmid":"26160174","id":"PMC_26160174","title":"The Role of the Pleckstrin Homology Domain-containing Protein CKIP-1 in Activation of p21-activated Kinase 1 (PAK1).","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26160174","citation_count":20,"is_preprint":false},{"pmid":"23524941","id":"PMC_23524941","title":"PAK1-deficiency/down-regulation reduces brood size, activates HSP16.2 gene and extends lifespan in Caenorhabditis elegans.","date":"2013","source":"Drug discoveries & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23524941","citation_count":20,"is_preprint":false},{"pmid":"31748572","id":"PMC_31748572","title":"PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31748572","citation_count":19,"is_preprint":false},{"pmid":"32237037","id":"PMC_32237037","title":"Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32237037","citation_count":18,"is_preprint":false},{"pmid":"37967011","id":"PMC_37967011","title":"PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosis.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37967011","citation_count":17,"is_preprint":false},{"pmid":"32433215","id":"PMC_32433215","title":"Fibrinogen Activates PAK1/Cofilin Signaling Pathway to Protect Endothelial Barrier Integrity.","date":"2021","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/32433215","citation_count":17,"is_preprint":false},{"pmid":"23514967","id":"PMC_23514967","title":"Depletion of PAK1 enhances ubiquitin-mediated survivin degradation in pancreatic β-cells.","date":"2013","source":"Islets","url":"https://pubmed.ncbi.nlm.nih.gov/23514967","citation_count":17,"is_preprint":false},{"pmid":"27681411","id":"PMC_27681411","title":"P21 (Cdc42/Rac)-activated kinase 1 (pak1) is associated with cardiotoxicity induced by antihistamines.","date":"2016","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/27681411","citation_count":17,"is_preprint":false},{"pmid":"36794533","id":"PMC_36794533","title":"Modulation of Rac1/PAK1/connexin43-mediated ATP release from astrocytes contributes to retinal ganglion cell survival in experimental glaucoma.","date":"2023","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/36794533","citation_count":17,"is_preprint":false},{"pmid":"36416208","id":"PMC_36416208","title":"Development and Utility of a PAK1-Selective Degrader.","date":"2022","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36416208","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49951,"output_tokens":10979,"usd":0.157269},"stage2":{"model":"claude-opus-4-6","input_tokens":14993,"output_tokens":5159,"usd":0.30591},"total_usd":0.463179,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"PAK1 directly phosphorylates LIM-kinase at threonine 508 within its activation loop, increasing LIM-kinase-mediated phosphorylation of cofilin tenfold in vitro; activated Rac/Cdc42 increases PAK1-LIMK association requiring both N-terminal regulatory and C-terminal catalytic domains of PAK1, thereby coupling Rac/Cdc42 signaling to actin depolymerization\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, dominant-negative interference, PAK1 autoinhibitory domain peptide inhibitor\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, replicated across multiple orthogonal methods in a highly-cited foundational paper\",\n      \"pmids\": [\"10559936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PAK1 acts as a downstream mediator of Rac/Cdc42 GTPases to activate the p38 MAP kinase; dominant-negative PAK1 suppresses both IL-1- and Rac/Cdc42-induced p38 activity, placing PAK1 in a kinase cascade leading to p38 and JNK activation\",\n      \"method\": \"Co-expression of constitutively active/dominant-negative GTPases and PAK1, p38 kinase activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with dominant-negative constructs, highly cited, replicated\",\n      \"pmids\": [\"7592586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PAK1 regulates actin cytoskeletal organization in mammalian cells; microinjection of activated PAK1 induces filopodia and membrane ruffles; PAK1 N-terminal mutants that cannot bind Cdc42/Rac1 show enhanced binding to the adapter protein Nck via a proline-rich SH3-binding region, and mutation of this proline residue alters cytoskeletal effects\",\n      \"method\": \"Microinjection, overexpression of mutants, co-immunoprecipitation, fluorescence microscopy\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, highly cited foundational paper\",\n      \"pmids\": [\"9395435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"PAK1 specifically interacts with the Nck adapter protein both in vitro and in vivo; Nck binds PAK1 through its second SH3 domain while PAK1 interacts with Nck via its first proline-rich SH3-binding motif; active PAK1 phosphorylates Nck at multiple sites; this interaction is strengthened upon PDGF receptor stimulation\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, in vivo phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus in vitro binding with domain mapping\",\n      \"pmids\": [\"8824201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Endogenous PAK1 localizes to pinocytic vesicles and co-localizes with F-actin in membrane ruffles and lamellipodia upon PDGF stimulation or Rac1 activation; PAK1 precedes F-actin in translocating to peripheral cytoskeletal structures; co-immunoprecipitation demonstrates in vivo interaction of PAK1 with filamentous actin; localization to actin structures is blocked by cytochalasin D and wortmannin\",\n      \"method\": \"Immunofluorescence microscopy, subcellular fractionation, co-immunoprecipitation, microinjection, pharmacological inhibition\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence, multiple orthogonal methods\",\n      \"pmids\": [\"9298982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Constitutively active PAK1 increases myosin light chain (MLC) phosphorylation and promotes directional cell motility; kinase-dead PAK1 has no effect on MLC phosphorylation and causes defects in directed motility; PAK1 kinase activity is required for polarized lamellipodia formation and persistent directional movement on fibronectin\",\n      \"method\": \"Tetracycline-inducible expression of wild-type, kinase-dead, and constitutively active PAK1; F-actin staining; MLC phosphorylation western blot; motility and chemotaxis assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean inducible KO/OE with defined molecular readouts and functional phenotypes\",\n      \"pmids\": [\"10330410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Activated (phosphorylated) PAK1 localizes to focal adhesions, filopodia, and lamellipodia edges in response to Cdc42/Rac1 or PDGF stimulation; PAK1 activation during wound closure is rapid, localizes to the leading edge, and is blocked by PI3-kinase and Src family kinase inhibitors but not EGFR inhibitor\",\n      \"method\": \"Phospho-specific antibody immunofluorescence, pharmacological inhibition, wound-healing assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — activation-state-specific antibody with direct spatial and temporal mapping, functional pharmacological dissection\",\n      \"pmids\": [\"11134074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PAK1 directly associates with Raf-1 in a manner dependent on PAK1's active conformation; active PAK1 phosphorylates Raf-1 at Ser338, a critical step for Raf-1 activation; the Raf-1 binding site maps to the C-terminus of the PAK1 catalytic domain; kinase-dead PAK1 barely binds Raf-1\",\n      \"method\": \"Co-immunoprecipitation under physiological and overexpressed conditions, in vitro kinase assay, domain mapping with deletion mutants, active-site mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with mutagenesis plus co-IP domain mapping\",\n      \"pmids\": [\"11733498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PI-3 kinase associates with the N-terminal regulatory domain (amino acids 67-150) of PAK1 in a Cdc42/Rac1-independent manner, leading to PAK1 activation; activated PAK1 directly phosphorylates actin, resulting in stress fiber dissolution and microfilament redistribution; kinase-dead PAK1 (K299R) and autoinhibitory domain peptide block actin phosphorylation\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, domain mapping with deletion/point mutants, cytoskeletal imaging\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with active-site mutagenesis and domain mapping\",\n      \"pmids\": [\"12181358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PAK1 physically interacts with protein phosphatase 2A (PP2A) and localizes to Z-disk, cell membrane, intercalated disc, and nuclear membrane in rat cardiac myocytes; constitutively active PAK1 reduces phosphorylation of cardiac troponin I (cTnI) and myosin binding protein C, associated with increased Ca2+ sensitivity\",\n      \"method\": \"Co-immunoprecipitation, adenoviral overexpression, immunofluorescence, Ca2+-tension measurements\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence, reciprocal Co-IP\",\n      \"pmids\": [\"14670848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PAK1 interacts with the Grb2 adapter protein via its second proline-rich SH3-binding domain; Grb2 mediates PAK1 association with the activated EGFR; blockade of this interaction by a cell-permeant TAT-tagged peptide decreased EGF-induced membrane lamellar extension\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding, TAT-peptide competition assay, cell morphology analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo Co-IP with domain mapping and functional consequence\",\n      \"pmids\": [\"12522133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PAK1 Thr212 is phosphorylated by Cdk5 (p35/Cdk5) or cyclin B1/Cdc2 in postmitotic neurons and mitotic cells respectively; developmental analysis shows Pak1T212(PO4) accumulates in corpus callosum, intermediate zone, and olfactory/commissural tracts in embryonic forebrain, and is absent in adult tissues\",\n      \"method\": \"Phospho-specific antibody immunofluorescence, developmental expression analysis, site-specific biochemical characterization\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — phospho-specific antibody localization, no direct functional rescue in this paper\",\n      \"pmids\": [\"12950086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structures of the free PAK1 kinase domain at 1.8 Å resolution reveal an essentially active conformation even without phosphorylation of Thr423; a phosphomimetic activation-loop mutation yields a very similar active conformation; the unphosphorylated kinase domain adopts an 'intermediate-active' state upon release from autoinhibitory dimerization\",\n      \"method\": \"X-ray crystallography at 1.8 Å, active-site and activation-loop mutagenesis\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with mutagenesis validation\",\n      \"pmids\": [\"15893667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CIB1, a 22-kDa Ca2+-binding protein, directly and specifically interacts with PAK1 within discrete regions surrounding the inhibitory switch domain in a calcium-dependent manner, activating PAK1 both in vitro and in vivo; CIB1 overexpression decreases cell migration through a PAK1/LIM kinase-dependent increase in cofilin phosphorylation; siRNA depletion of CIB1 reduces adhesion-induced PAK1 activation\",\n      \"method\": \"Pulldown, co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, cell migration assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus in vitro kinase activation plus genetic loss-of-function with functional readout\",\n      \"pmids\": [\"16061695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PAK1 phosphorylates SHARP (a Notch signaling co-repressor) at Ser3486 and Thr3568 within its repression domain; this interaction enhances SHARP-mediated repression of Notch target genes; inhibition of PAK1 or mutation of phosphorylation sites abolishes SHARP co-repressor function\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro phosphorylation with site mapping, reporter gene assay, PAK1 siRNA\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with phosphosite mapping plus mutagenesis plus reporter functional assay\",\n      \"pmids\": [\"15824732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CRIPak is an endogenous PAK1 inhibitor that interacts with PAK1 through its N-terminal regulatory domain; CRIPak inhibits PAK1 kinase activity in vitro and in vivo, blocks PAK1-mediated LIMK activation and estrogen receptor transactivation; siRNA knockdown of CRIPak increases PAK1 activity and cytoskeletal remodeling\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, ER transactivation reporter\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with domain mapping and genetic loss-of-function\",\n      \"pmids\": [\"16278681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PAK1 resides in a complex with atypical PKCζ and myosin II-B in an EGF-dependent manner; PAK1 is involved in aPKCζ phosphorylation, and aPKCζ in turn directly phosphorylates myosin II-B on a specific serine residue, leading to slower filament assembly of myosin II-B isoform specifically\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, dominant-negative/knockdown experiments, myosin II-B filament assembly assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with isoform specificity demonstrated, reciprocal Co-IP\",\n      \"pmids\": [\"16611744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Autophosphorylation of PAK1 triggered by Rho-family GTPase Chp leads to PAK1 ubiquitination and proteasomal degradation; Chp-induced degradation requires the PAK1 p21-binding domain, kinase activity, and autophosphorylation sites, but not PIX- or Nck-binding sites; Chp provides a function distinct from kinase activation to trigger PAK1 degradation\",\n      \"method\": \"Overexpression, ubiquitination assay, proteasome inhibitor treatment, domain mapping with deletion mutants, functional cell migration assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection of ubiquitin-proteasome degradation with domain mapping and kinase-dead controls\",\n      \"pmids\": [\"17355222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Adhesion stimulates a direct physical association between PAK1 and ERK1/2; far-western analysis shows direct protein-protein interaction; peptide mapping identifies an ERK2-binding site within the PAK1 autoinhibitory domain; ERK2 phosphorylates PAK1 at Thr212 in vitro and in smooth muscle cells in an adhesion- and MEK/ERK-dependent manner; PAK-T212E phosphomimetic attenuates downstream ERK signaling, suggesting negative feedback\",\n      \"method\": \"Co-immunoprecipitation, far-western blotting, in vitro kinase assay, peptide mapping, phosphomimetic mutagenesis, reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with phosphosite mapping plus far-western direct interaction plus functional reporter\",\n      \"pmids\": [\"15542607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Pak1 depletion by siRNA interferes with heregulin-mediated dephosphorylation of cofilin and lamellipodial protrusion; Pak1 depletion decreases phospho-MLC levels whereas Pak2 depletion increases them, demonstrating isoform-specific opposite roles in MLC phosphorylation and focal adhesion maturation\",\n      \"method\": \"siRNA knockdown, western blot for cofilin and MLC phosphorylation, focal adhesion immunofluorescence, invasion assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — isoform-specific siRNA with multiple molecular readouts\",\n      \"pmids\": [\"18411304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PAK1 directly interacts with dynein light chain LC8 via residues 212-222; NMR and crystallographic studies show PAK1 binds along the same groove as canonical LC8 partners but with a distinct hydrogen-bond network; LC8 binding interface requires LC8 dimerization and precludes phosphorylation of LC8 at Ser88; in vitro phosphorylation assays show activated PAK1 fails to phosphorylate LC8\",\n      \"method\": \"X-ray crystallography, NMR, in vitro phosphorylation assay, LC8 point mutagenesis, biochemical binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus NMR plus in vitro kinase assay with mutagenesis\",\n      \"pmids\": [\"18650427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A FRET-based conformational biosensor reveals PAK1 acquires an intermediate semi-open conformational state upon recruitment to the plasma membrane, selectively autophosphorylated on N-terminal serines but not Thr423; this intermediate is hypersensitive to Cdc42/Rac1 stimulation; PIX proteins contribute to PAK1 stimulation at membrane protrusions in a GTPase-independent way; trans-phosphorylation events occur between PAK1 molecules at the membrane\",\n      \"method\": \"FRET biosensor, live-cell imaging, pharmacological and genetic perturbations\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — FRET biosensor with spatiotemporal resolution, multiple mechanistic insights validated in live cells\",\n      \"pmids\": [\"19574218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FOXO transcription factors directly regulate PAK1 gene expression as a transcriptional target; PAK1 acts locally in neuronal processes to induce polarity; knockdown of PAK1 phenocopies FOXO knockdown on neuronal polarity; exogenous PAK1 expression rescues polarity defects caused by FOXO knockdown in neurons in vivo\",\n      \"method\": \"Chromatin immunoprecipitation, shRNA knockdown, in vivo rescue experiments in rat cerebellar cortex, neuronal morphology analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct transcriptional target identification plus genetic epistasis with in vivo rescue\",\n      \"pmids\": [\"20395366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PAK1 is required for second/sustained-phase insulin secretion in pancreatic β-cells; PAK1 activation is Cdc42-dependent and signals downstream to activate ERK1/2; PAK1 knockout mice show whole-body glucose intolerance and peripheral insulin resistance; in skeletal muscle, PAK1 loss causes defective cofilin phosphorylation and impaired GLUT4 translocation\",\n      \"method\": \"PAK1 knockout mice, islet isolation and insulin secretion assay, glucose tolerance testing, GLUT4 translocation assay, western blot for ERK and cofilin phosphorylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO model with multiple defined molecular and functional readouts, human islet validation\",\n      \"pmids\": [\"21969371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CYK4 (part of the centralspindlin complex) acts as a GAP for Rac1 and inhibits Rac1-dependent PAK1 and ARHGEF7 effector pathways at the cell equator during cytokinesis; CYK4 GAP mutants show elevated PAK1 activity and defects in cytokinesis that are rescued by depletion of PAK1 or ARHGEF7\",\n      \"method\": \"GAP mutant expression, Rac1 activity assay, PAK1/ARHGEF7 depletion rescue, immunofluorescence, cytokinesis phenotype scoring\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with rescue experiment and defined molecular pathway\",\n      \"pmids\": [\"22945935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PAK1 can promote ERK/MEK activation in a kinase-independent manner; kinase-dead PAK1 overexpression increases MEK1/2 and ERK phosphorylation without affecting B-RAF or C-RAF Ser338 phosphorylation; activated Rac1 induces formation of a triple complex of Rac1, PAK1, and MEK1 independently of PAK1 kinase activity, suggesting a scaffold function for C-RAF interactions\",\n      \"method\": \"Kinase-dead PAK1 overexpression, western blot for downstream phosphorylation, co-immunoprecipitation of Rac1-PAK1-MEK1 complex\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistically novel scaffold finding, single lab with co-IP and kinase-dead controls\",\n      \"pmids\": [\"23653349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"HIV Nef recruits Pak1 and Pak2 to phosphorylate paxillin differentially: Pak1 phosphorylates paxillin at Ser258, which inhibits TACE/ADAM17 association and lipid raft transfer; Pak2 phosphorylates paxillin at Ser272/274 to induce TACE-paxillin association and extracellular vesicle shuttling\",\n      \"method\": \"Co-immunoprecipitation, site-specific phosphorylation mapping, extracellular vesicle fractionation, site-directed mutagenesis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-specific phosphorylation mapping with mutagenesis establishing distinct functions of PAK1 vs PAK2\",\n      \"pmids\": [\"23317503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A TrioGEF-Rac1-PAK1 signaling axis drives invadopodia disassembly; Rac1 FRET biosensor shows Rac1 activity is excluded from invadopodia cores and activated during disassembly; PAK1 downstream of Rac1 phosphorylates cortactin, causing invadopodia dissolution\",\n      \"method\": \"FRET biosensor, photoactivatable Rac1, pharmacological and genetic inhibition, cortactin phosphorylation analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — FRET biosensor plus photoactivation plus epistasis defining Trio-Rac1-PAK1-cortactin pathway\",\n      \"pmids\": [\"24859002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PAK1 inhibits nuclear translocation of Stat5 downstream of a FAK/Tiam1/Rac1/PAK1 pathway in FLT3- and KIT-driven leukemia cells; PAK1 inhibition prolongs survival of leukemic mice by blocking Stat5 nuclear translocation\",\n      \"method\": \"Pharmacological inhibition, shRNA knockdown, nuclear fractionation, mouse leukemia model survival analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined pathway with in vivo rescue, single lab\",\n      \"pmids\": [\"25456130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"JAK2 kinase phosphorylates PAK1 on tyrosine residues in response to irradiation, which is essential for PAK1 protein stability and binding to Snail; this JAK2-PAK1-Snail pathway promotes EMT and radioresistance in lung cancer cells\",\n      \"method\": \"JAK2 inhibitor treatment, co-immunoprecipitation, phosphorylation western blot, PAK1 stability assay, EMT marker analysis, xenograft model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP with kinase inhibitor showing phosphorylation-dependent stability and Snail binding, single lab\",\n      \"pmids\": [\"25125660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pak1 is required for ventricular Ca2+ homeostasis; cardiomyocyte-specific Pak1 deletion causes ventricular arrhythmias during β-adrenergic stress; Pak1 regulates SERCA2a expression through a transcriptional mechanism involving serum response factor (SRF); constitutively active Pak1 increases SERCA2a mRNA and protein\",\n      \"method\": \"Conditional cardiac Pak1 knockout, adenoviral overexpression, calcium imaging, electrophysiology, SERCA2a western blot and qPCR, SRF pathway analysis\",\n      \"journal\": \"Circulation. Arrhythmia and electrophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific knockout with mechanistic transcriptional pathway and multiple functional readouts\",\n      \"pmids\": [\"25217043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CK2α-interacting protein CKIP-1 mediates interaction between CK2α and PAK1 at membrane ruffles in a PI3K-dependent manner; PAK1 phosphorylation at Ser-223 by CK2 requires CKIP-1; PAK1 mediates phosphorylation of p41-Arc at the plasma membrane requiring PI3K and CKIP-1; CKIP-1 knockdown suppresses PAK1-mediated cell migration and invasion\",\n      \"method\": \"Co-immunoprecipitation, phosphorylation assays, siRNA knockdown, PI3K inhibition, cell migration/invasion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel activation mechanism with Co-IP and functional validation, single lab\",\n      \"pmids\": [\"26160174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GIT1/βPIX signaling proteins form complexes with γ-tubulin and PAK1 at centrosomes; depletion of PAK1 or inhibition of its kinase activity reduces microtubule nucleation from interphase centrosomes; in vitro kinase assays show GIT1 and βPIX (but not γ-tubulin) are PAK1 substrates; direct interaction of γ-tubulin with βPIX C-terminal domain and GIT1 N-terminal domain was demonstrated by pulldown\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, microtubule regrowth assay, phenotypic rescue, pulldown\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay plus pulldown plus functional microtubule regrowth assay\",\n      \"pmids\": [\"27012601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p27Kip1 promotes interaction of Cortactin with PAK1; PAK1 phosphorylates Cortactin to promote invadopodia turnover; Cortactin mutants at PAK1-targeted phosphorylation sites abolish p27's effect on invadopodia dynamics; in absence of p27, impaired PAK1-Cortactin interaction leads to increased invadopodia stability\",\n      \"method\": \"Co-immunoprecipitation, phospho-mutant expression, invadopodia dynamics assay, invasion assay, Rac1 pathway analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus phospho-mutant functional rescue defining PAK1-Cortactin pathway\",\n      \"pmids\": [\"28287395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"De novo PAK1 mutations (Y131C, Y429C) reduce PAK1 dimerization as shown by co-immunoprecipitation and size-exclusion chromatography; reduced dimerization correlates with gain-of-function kinase activity; patient fibroblasts show enhanced phosphorylation of JNK, AKT, and c-JUN; PAK1 inhibitor FRAX486 reverses the filopodia-enriched cellular phenotype\",\n      \"method\": \"Co-immunoprecipitation, size-exclusion chromatography, phosphorylation western blot, cell spreading assay, PAK1 inhibitor rescue\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods demonstrating gain-of-function mechanism through impaired dimerization\",\n      \"pmids\": [\"30290153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RIT1 directly interacts with PAK1 as a novel effector; RIT1 also directly interacts with CDC42 and RAC1 independently of guanine nucleotide binding; the RIT1-PAK1 complex regulates actin cytoskeletal rearrangements (stress fiber dissolution, focal adhesion reduction); disease-causing RIT1 mutations enhance PAK1, CDC42, and RAC1 interactions; kinase-dead PAK1 prevents RIT1-mediated cytoskeletal effects\",\n      \"method\": \"Pulldown with purified recombinant proteins, co-immunoprecipitation, heterologous expression, cell morphology analysis, migration assay, kinase-dead rescue\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with purified proteins plus functional rescue with kinase-dead PAK1\",\n      \"pmids\": [\"29734338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PAK1 loss in atrial myocytes increases Rac1 membrane translocation, enhances NOX2-dependent ROS production, and exaggerates AngII-induced intracellular Ca2+ increase leading to arrhythmic events via NCX activity; PAK1 stimulation (FTY720) attenuates NCX-dependent Ca2+ overload by suppressing NOX2-dependent ROS\",\n      \"method\": \"PAK1 knockout mice, AngII stimulation, NOX2 inhibitors, NCX inhibitors, Ca2+ imaging, electrophysiology, ROS measurement\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with pharmacological pathway dissection and multiple molecular readouts\",\n      \"pmids\": [\"29625277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Hypoxia induces ELP3-mediated acetylation of PAK1 at K420, which suppresses PAK1 dimerization and enhances kinase activity; activated PAK1 phosphorylates ATG5 at T101, protecting it from ubiquitin-dependent degradation and increasing affinity of the ATG12-ATG5 complex for ATG16L1, promoting autophagosome formation; SIRT1-mediated deacetylation of PAK1 at K420 opposes this pathway\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, ubiquitination assay, autophagy flux assay, shRNA knockdown, inhibitor studies\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with site-specific mutagenesis of acetylation and phosphorylation sites, writer/eraser identified\",\n      \"pmids\": [\"32186433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PP1A serves as the phosphatase in Smad4-mediated dephosphorylation of PAK1-T423; MYO18A acts as the PP1-interacting protein for substrate recognition; the Smad4-MYO18A-PP1A complex dephosphorylates PAK1-T423, thereby inhibiting PAK1-mediated β-catenin Ser675 phosphorylation and its nuclear translocation in cholangiocarcinoma\",\n      \"method\": \"LC-MS/MS, co-immunoprecipitation, in vitro phosphatase assay, domain mapping (RVFFR motif, CC domain), β-catenin localization, cell proliferation/invasion assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — LC-MS/MS substrate identification plus in vitro phosphatase assay plus domain mapping\",\n      \"pmids\": [\"34799729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PAK1 promotes oligodendrocyte morphologic change and myelin production; inhibiting PAK1 early in oligodendrocyte development decreases morphologic complexity and alters F-actin spreading; constitutively activating AKT increases PAK1 expression; constitutively active PAK1 in zebrafish increases myelin internode length while PAK1 inhibition decreases it\",\n      \"method\": \"In vitro oligodendrocyte culture, PAK1 inhibitor treatment, constitutively active PAK1 expression in zebrafish, F-actin imaging, myelin internode measurement\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo model with functional readouts, single lab\",\n      \"pmids\": [\"33478987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Skeletal muscle PAK1 is required for insulin-stimulated GLUT4 vesicle translocation via a non-canonical pathway involving downstream effector ARPC1B; inducible skeletal muscle-specific PAK1 knockout impairs whole-body glucose homeostasis; PAK1-enriched muscle conditioned media enhances β-cell function, revealing tissue crosstalk\",\n      \"method\": \"Inducible muscle-specific knockout and overexpression mouse models, glucose/insulin tolerance testing, GLUT4-myc translocation assay, conditioned media experiments\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific inducible KO/OE with multiple functional readouts and mechanistic pathway identification\",\n      \"pmids\": [\"35222279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A PAK1-selective PROTAC degrader (BJG-05-039) using NVS-PAK1-1 allosteric inhibitor conjugated to lenalidomide induces selective PAK1 degradation via Cereblon E3 ubiquitin ligase; selective PAK1 degradation shows enhanced anti-proliferative effects relative to catalytic inhibition in PAK1-dependent but not PAK2-dependent cell lines\",\n      \"method\": \"PROTAC synthesis, protein degradation assay, anti-proliferation assay in PAK1 vs PAK2-dependent cell lines\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — selective degrader tool demonstrating PAK1-specific dependency, single study\",\n      \"pmids\": [\"36416208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Mechanical stress from fibrotic scarring induces PAK1-dependent nuclear softening and loss of H3K9Me3 heterochromatin repression; genetic loss of PAK1-dependent signaling impairs the mechanoadaptive response in vitro and dramatically improves fibrosis in liver and lung in vivo; PAK1 regulates actomyosin-dependent chromatin remodeling in myofibroblasts\",\n      \"method\": \"Genetic PAK1 manipulation, chromatin accessibility profiling (ATAC-seq), RNA-seq, nuclear mechanics assays, mouse liver and lung fibrosis models\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic manipulation with multi-omic readouts in vivo, single lab\",\n      \"pmids\": [\"37967011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"PAK1 is rapidly activated downstream of TCR signaling in a Lck-, Vav-, and Cdc42-dependent manner and associates with tyrosine-phosphorylated Nck; dominant-negative PAK1 or Nck specifically inhibits TCR-mediated NFAT activation and ERK2 activation but not JNK activation, placing Pak1 in a JNK-independent pathway for gene expression\",\n      \"method\": \"Co-immunoprecipitation, kinase activity assay, dominant-negative inhibition, NFAT and ERK reporter assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with dominant-negative constructs and specific reporter assays defining pathway position\",\n      \"pmids\": [\"9755165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Fibrinogen activates PAK1 (phosphorylation) via syndecan-1, which in turn activates (dephosphorylates) cofilin, leading to disassembly of stress fibers and reduction of endothelial permeability; PAK1 silencing prevents fibrinogen-induced cofilin dephosphorylation and barrier protection\",\n      \"method\": \"Western blot for PAK1 and cofilin phosphorylation, siRNA knockdown, FITC-dextran permeability assay, in vivo hemorrhagic shock model\",\n      \"journal\": \"Shock\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA loss-of-function with defined molecular and functional readout, in vivo confirmation\",\n      \"pmids\": [\"32433215\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAK1 is a serine/threonine kinase activated by GTP-bound Rac1/Cdc42 (or by PI3K, CIB1, CK2/CKIP-1, ELP3-mediated acetylation, or Etk/Bmx tyrosine phosphorylation) that, upon release from autoinhibitory homodimerization, phosphorylates a defined set of substrates—including LIM-kinase (Thr508), cofilin, Raf-1 (Ser338), MEK1 (Ser298), myosin light chain, cortactin, ATG5 (Thr101), SHARP, cardiac troponin I, and paxillin—to regulate actin and microtubule cytoskeletal dynamics, cell migration, invadopodia turnover, MAPK/ERK cascade activation (also via a kinase-independent scaffold function), Notch and autophagy signaling, GLUT4 translocation, SERCA2a-dependent cardiac Ca2+ homeostasis, and nuclear mechanotransduction in fibroblasts, while being negatively regulated by PP1A-mediated dephosphorylation of Thr423, CRIPak binding, Cdc42/Chp-induced autophosphorylation-dependent proteasomal degradation, and FOXO-driven transcriptional suppression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PAK1 is a Rac1/Cdc42-activated serine/threonine kinase that serves as a central integrator of cytoskeletal dynamics, MAPK signaling, and diverse tissue-specific physiological processes. Upon release from its autoinhibitory homodimer—whose crystal structure reveals an intermediate-active kinase domain conformation even without Thr423 phosphorylation—PAK1 phosphorylates LIM-kinase (Thr508), myosin light chain, cortactin, Raf-1 (Ser338), ATG5 (Thr101), SHARP, and paxillin to control actin remodeling, directed cell migration, invadopodia turnover, ERK cascade activation (including a kinase-independent scaffold function bridging Rac1 to MEK1), Notch target gene repression, and autophagosome formation [PMID:10559936, PMID:10330410, PMID:11733498, PMID:24859002, PMID:32186433, PMID:15824732, PMID:23653349]. Beyond cytoskeletal regulation, PAK1 is essential for insulin-stimulated GLUT4 translocation in skeletal muscle, SERCA2a-dependent cardiac Ca²⁺ homeostasis, oligodendrocyte myelination, nuclear mechanotransduction in fibroblasts, and NFAT activation downstream of the T-cell receptor [PMID:35222279, PMID:25217043, PMID:33478987, PMID:37967011, PMID:9755165]. De novo gain-of-function PAK1 mutations (Y131C, Y429C) that impair autoinhibitory dimerization cause a neurodevelopmental disorder with enhanced JNK/AKT signaling [PMID:30290153].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing PAK1 as a kinase effector downstream of Rac/Cdc42 GTPases that activates stress-activated MAP kinase pathways answered the fundamental question of how Rho-family GTPase signals reach p38 and JNK cascades.\",\n      \"evidence\": \"Dominant-negative PAK1 blocks Rac/Cdc42- and IL-1-induced p38 activation in co-expression assays\",\n      \"pmids\": [\"7592586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation of MAP3K intermediates not shown\", \"Upstream mechanism of PAK1 activation not yet defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of the Nck adapter as a direct PAK1-binding partner via SH3-domain interactions revealed how receptor tyrosine kinase signaling (e.g., PDGFR) recruits PAK1 to signaling complexes.\",\n      \"evidence\": \"Reciprocal co-IP and in vitro binding with domain mapping of Nck SH3-2 and PAK1 proline-rich motif\",\n      \"pmids\": [\"8824201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Nck-mediated PAK1 recruitment not yet demonstrated\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that activated PAK1 directly reorganizes the actin cytoskeleton—inducing filopodia and membrane ruffles—and localizes to F-actin-rich structures established PAK1 as a direct cytoskeletal effector rather than merely a kinase cascade component.\",\n      \"evidence\": \"Microinjection of activated PAK1, immunofluorescence co-localization with F-actin, co-IP with filamentous actin, pharmacological inhibitor studies\",\n      \"pmids\": [\"9395435\", \"9298982\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct actin-binding substrates not yet identified\", \"Kinase-dependent vs. kinase-independent cytoskeletal effects not resolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Placing PAK1 in TCR signaling downstream of Lck/Vav/Cdc42 and upstream of NFAT and ERK2 (but not JNK) demonstrated PAK1 functions in immune cell gene expression beyond stress kinase cascades.\",\n      \"evidence\": \"Dominant-negative PAK1 blocks NFAT and ERK2 reporters in T cells; co-IP with phospho-Nck after TCR stimulation\",\n      \"pmids\": [\"9755165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct substrates mediating NFAT activation not identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of LIM-kinase Thr508 and myosin light chain as direct PAK1 substrates connected PAK1 activity to specific molecular steps in actin depolymerization and directed cell motility.\",\n      \"evidence\": \"In vitro kinase assay with mutagenesis for LIMK Thr508; inducible expression of kinase-dead/active PAK1 with MLC phosphorylation and chemotaxis readouts\",\n      \"pmids\": [\"10559936\", \"10330410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PAK1 phosphorylates MLC directly or through MLCK not fully resolved\", \"Spatial regulation of substrate phosphorylation in vivo unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that PAK1 directly phosphorylates Raf-1 at Ser338 established PAK1 as a critical input for MAPK/ERK cascade activation independent of Ras-mediated Raf recruitment.\",\n      \"evidence\": \"Co-IP of endogenous PAK1–Raf-1 complex, in vitro kinase assay showing Ser338 phosphorylation, domain mapping\",\n      \"pmids\": [\"11733498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of PAK1 vs. other Raf-1 Ser338 kinases in vivo unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing that PI3K binds and activates PAK1 independently of Cdc42/Rac1 revealed a second, GTPase-independent activation route and direct actin phosphorylation as a mechanism for stress fiber dissolution.\",\n      \"evidence\": \"Co-IP with domain mapping, in vitro kinase assay on actin, kinase-dead control\",\n      \"pmids\": [\"12181358\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of direct actin phosphorylation needs in vivo confirmation\", \"Actin phosphorylation site not mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Multiple discoveries expanded PAK1's interaction network: cardiac localization with PP2A and troponin I regulation, EGFR-Grb2-mediated recruitment to membranes, and Cdk5-mediated Thr212 phosphorylation in neurons broadened PAK1 function to cardiac contractility and neuronal development.\",\n      \"evidence\": \"Co-IP in cardiac myocytes with Ca²⁺-tension measurements; Grb2 binding via SH3 domain with TAT-peptide competition; phospho-specific antibody in embryonic brain\",\n      \"pmids\": [\"14670848\", \"12522133\", \"12950086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct troponin I phosphatase mechanism downstream of PAK1-PP2A unclear\", \"Functional consequence of Thr212 phosphorylation in neurons not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstration that ERK2 phosphorylates PAK1 at Thr212 in an adhesion-dependent manner, with the phosphomimetic attenuating ERK signaling, established a negative feedback loop between PAK1 and the ERK pathway.\",\n      \"evidence\": \"Far-western confirming direct interaction, in vitro kinase assay with site mapping, phosphomimetic reporter assay\",\n      \"pmids\": [\"15542607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of feedback loop not tested genetically\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Crystal structures at 1.8 Å resolution revealing that the PAK1 kinase domain adopts a near-active conformation even without Thr423 phosphorylation fundamentally reframed the activation model: autoinhibitory dimerization, not activation-loop phosphorylation, is the primary constraint on activity.\",\n      \"evidence\": \"X-ray crystallography of free and phosphomimetic kinase domains\",\n      \"pmids\": [\"15893667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length PAK1 dimer structure not solved\", \"Dynamics of dimer-to-monomer transition not captured\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of CIB1 as a calcium-dependent PAK1 activator and CRIPak as an endogenous PAK1 inhibitor defined two new regulatory inputs controlling PAK1 kinase output and its downstream effects on LIMK/cofilin.\",\n      \"evidence\": \"In vitro kinase activation by CIB1, siRNA depletion reducing adhesion-induced PAK1 activation; CRIPak Co-IP and in vitro kinase inhibition with siRNA derepression\",\n      \"pmids\": [\"16061695\", \"16278681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CIB1 and CRIPak binding sites on PAK1 not precisely mapped structurally\", \"In vivo physiological contexts for CIB1/CRIPak regulation not established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstration that Chp GTPase triggers PAK1 autophosphorylation-dependent ubiquitination and proteasomal degradation revealed a turnover mechanism distinct from kinase activation, explaining how cells reset PAK1 signaling.\",\n      \"evidence\": \"Ubiquitination assay with proteasome inhibitor, domain mapping with kinase-dead and autophosphorylation-site mutants\",\n      \"pmids\": [\"17355222\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ubiquitin ligase identity not determined\", \"Physiological trigger for Chp-mediated PAK1 degradation unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A FRET-based conformational biosensor revealed that PAK1 adopts an intermediate semi-open state at the plasma membrane, selectively autophosphorylated on N-terminal serines, providing the first real-time visualization of spatially regulated PAK1 activation dynamics.\",\n      \"evidence\": \"FRET biosensor in live cells with pharmacological and genetic perturbations\",\n      \"pmids\": [\"19574218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of semi-open intermediate not resolved\", \"Whether intermediate state exists for other PAK family members unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"PAK1 knockout mice revealed essential roles in glucose homeostasis: PAK1 is required for sustained insulin secretion from β-cells and for GLUT4 translocation in skeletal muscle via cofilin phosphorylation, linking cytoskeletal kinase function to metabolic regulation.\",\n      \"evidence\": \"Global PAK1 KO with glucose tolerance testing, islet insulin secretion, GLUT4 translocation, and ERK/cofilin phosphorylation readouts\",\n      \"pmids\": [\"21969371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific contributions not dissected in this global KO\", \"Direct PAK1 substrates in β-cell exocytosis not identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that kinase-dead PAK1 still promotes MEK/ERK activation by scaffolding a Rac1–PAK1–MEK1 complex established a kinase-independent mechanism for MAPK pathway engagement, broadening PAK1's signaling repertoire beyond its catalytic activity.\",\n      \"evidence\": \"Kinase-dead PAK1 overexpression increases MEK/ERK phosphorylation; co-IP of Rac1-PAK1-MEK1 triple complex\",\n      \"pmids\": [\"23653349\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Scaffold function not yet shown with endogenous protein levels\", \"Structural basis of scaffold interaction unknown\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Multiple studies defined PAK1 as an effector in invadopodia dynamics (phosphorylating cortactin downstream of Trio-Rac1), cardiac physiology (regulating SERCA2a via SRF transcription in cardiomyocytes), and as a paxillin Ser258 kinase in HIV Nef-mediated vesicle trafficking.\",\n      \"evidence\": \"FRET/photoactivation for invadopodia; conditional cardiac KO with Ca²⁺ imaging and SERCA2a qPCR; site-specific phospho-mapping of paxillin with mutagenesis\",\n      \"pmids\": [\"24859002\", \"25217043\", \"23317503\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PAK1-cortactin phosphorylation triggers disassembly structurally undefined\", \"SRF cofactor mediating PAK1 transcriptional effect not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Patient mutations (Y131C, Y429C) that reduce PAK1 dimerization cause constitutive kinase activation, linking the autoinhibitory dimer model to human neurodevelopmental disease and validating dimerization as the primary restraint on PAK1 activity in vivo.\",\n      \"evidence\": \"Co-IP and SEC showing reduced dimerization, enhanced JNK/AKT phosphorylation in patient fibroblasts, rescue by PAK1 inhibitor FRAX486\",\n      \"pmids\": [\"30290153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full spectrum of downstream targets dysregulated by gain-of-function mutations not catalogued\", \"Neuronal-specific pathomechanism not dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of ELP3-mediated acetylation at K420 as an activation switch that drives PAK1-dependent ATG5 Thr101 phosphorylation and autophagosome formation connected PAK1 to autophagy regulation via a hypoxia-responsive post-translational code.\",\n      \"evidence\": \"In vitro kinase assay, K420 acetylation/deacetylation mutagenesis, ubiquitination assay for ATG5, autophagy flux measurement\",\n      \"pmids\": [\"32186433\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of ELP3-PAK1-ATG5 axis in tissue-specific autophagy not tested\", \"Whether SIRT1-mediated deacetylation is the sole eraser unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of the Smad4-MYO18A-PP1A complex as the phosphatase targeting PAK1-Thr423 resolved how PAK1 activity is terminated and connected PAK1 inactivation to suppression of β-catenin nuclear translocation.\",\n      \"evidence\": \"LC-MS/MS identification, in vitro phosphatase assay, domain mapping of RVFFR motif, β-catenin localization in cholangiocarcinoma cells\",\n      \"pmids\": [\"34799729\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this phosphatase complex operates in tissues beyond cholangiocarcinoma not tested\", \"Other PAK1 phosphatases may exist\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Inducible skeletal-muscle-specific PAK1 knockout confirmed a non-redundant role in GLUT4 translocation via ARPC1B and revealed muscle-to-β-cell crosstalk through secreted factors, establishing PAK1 as a systemic metabolic regulator.\",\n      \"evidence\": \"Inducible muscle-specific KO/OE mice, glucose/insulin tolerance, GLUT4-myc translocation, conditioned media on β-cells\",\n      \"pmids\": [\"35222279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of PAK1-dependent myokines unknown\", \"ARPC1B phosphorylation site not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstration that PAK1 drives nuclear softening and H3K9Me3 heterochromatin loss in mechanically stressed fibroblasts, with PAK1 loss improving fibrosis in vivo, revealed a nuclear mechanotransduction function beyond its classical cytoplasmic roles.\",\n      \"evidence\": \"Genetic PAK1 manipulation with ATAC-seq, RNA-seq, nuclear mechanics, mouse liver/lung fibrosis models\",\n      \"pmids\": [\"37967011\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct nuclear substrates of PAK1 mediating chromatin remodeling not identified\", \"Whether PAK1 translocates to the nucleus or acts through cytoplasmic intermediaries unclear\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full-length autoinhibitory dimer structure, the identity of the E3 ligase(s) mediating PAK1 ubiquitination, the direct nuclear substrates through which PAK1 remodels chromatin, and the identity of PAK1-dependent myokines mediating muscle-to-islet crosstalk.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Full-length PAK1 dimer crystal structure not available\", \"E3 ubiquitin ligase for Chp-induced PAK1 degradation unknown\", \"Nuclear mechanotransduction substrates not identified\", \"Myokine identity downstream of muscle PAK1 undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 5, 7, 8, 14, 26, 27, 33, 37]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [4, 2, 5]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 6, 21]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [2, 4, 5, 6]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [32]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 7, 18, 25, 43]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [6, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [37]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [17, 38]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [23, 40]}\n    ],\n    \"complexes\": [\n      \"PAK1 autoinhibitory homodimer\"\n    ],\n    \"partners\": [\n      \"RAC1\",\n      \"CDC42\",\n      \"NCK1\",\n      \"LIMK1\",\n      \"RAF1\",\n      \"GRB2\",\n      \"ARHGEF7\",\n      \"CIB1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}